Glycation-dependent	O
,	O
reactive	O
oxygen	O
species-mediated	O
suppression	O
of	O
the	O
insulin	O
gene	O
promoter	O
activity	O
in	O
HIT	B-cell_type
cells	I-cell_type
.	O

Prolonged	O
poor	O
glycemic	O
control	O
in	O
non-insulin-dependent	O
diabetes	O
mellitus	O
patients	O
often	O
leads	O
to	O
a	O
decline	O
in	O
insulin	O
secretion	O
from	O
pancreatic	B-cell_type
beta	I-cell_type
cells	I-cell_type
,	O
accompanied	O
by	O
a	O
decrease	O
in	O
the	O
insulin	O
content	O
of	O
the	O
cells	O
.	O

As	O
a	O
step	O
toward	O
elucidating	O
the	O
pathophysiological	O
background	O
of	O
the	O
so-called	O
glucose	O
toxicity	O
to	O
pancreatic	B-cell_type
beta	I-cell_type
cells	I-cell_type
,	O
we	O
induced	O
glycation	O
in	O
HIT-T15	B-cell_type
cells	I-cell_type
using	O
a	O
sugar	O
with	O
strong	O
deoxidizing	O
activity	O
,	O
D-ribose	O
,	O
and	O
examined	O
the	O
effects	O
on	O
insulin	O
gene	O
transcription	O
.	O

The	O
results	O
of	O
reporter	B-DNA
gene	I-DNA
analyses	O
revealed	O
that	O
the	O
insulin	B-DNA
gene	I-DNA
promoter	I-DNA
is	O
more	O
sensitive	O
to	O
glycation	O
than	O
the	O
control	O
beta-actin	B-DNA
gene	I-DNA
promoter	I-DNA
;	O
approximately	O
50	O
and	O
80	O
%	O
of	O
the	O
insulin	B-DNA
gene	I-DNA
promoter	I-DNA
activity	O
was	O
lost	O
when	O
the	O
cells	O
were	O
kept	O
for	O
3	O
d	O
in	O
the	O
presence	O
of	O
40	O
and	O
60	O
mM	O
D-ribose	O
,	O
respectively	O
.	O

In	O
agreement	O
with	O
this	O
,	O
decrease	O
in	O
the	O
insulin	B-RNA
mRNA	I-RNA
and	O
insulin	O
content	O
was	O
observed	O
in	O
the	O
glycation-induced	B-cell_type
cells	I-cell_type
.	O

Also	O
,	O
gel	O
mobility	O
shift	O
analyses	O
using	O
specific	O
antiserum	O
revealed	O
decrease	O
in	O
the	O
DNA-binding	O
activity	O
of	O
an	O
insulin	B-protein
gene	I-protein
transcription	I-protein
factor	I-protein
,	O
PDX-1/IPF1/STF-1	B-protein
.	O

These	O
effects	O
of	O
D-ribose	O
seemed	O
almost	O
irreversible	O
but	O
could	O
be	O
prevented	O
by	O
addition	O
of	O
1	O
mM	O
aminoguanidine	O
or	O
10	O
mM	O
N-acetylcysteine	O
,	O
thus	O
suggesting	O
that	O
glycation	O
and	O
reactive	O
oxygen	O
species	O
,	O
generated	O
through	O
the	O
glycation	O
reaction	O
,	O
serve	O
as	O
mediators	O
of	O
the	O
phenomena	O
.	O

These	O
observations	O
suggest	O
that	O
protein	O
glycation	O
in	O
pancreatic	B-cell_type
beta	I-cell_type
cells	I-cell_type
,	O
which	O
occurs	O
in	O
vivo	O
under	O
chronic	O
hyperglycemia	O
,	O
suppresses	O
insulin	O
gene	O
transcription	O
and	O
thus	O
can	O
explain	O
part	O
of	O
the	O
beta	O
cell	O
glucose	O
toxicity	O
.	O

Glycation-dependent	NULL
,	NULL
Reactive	NULL
Oxygen	NULL
Species-mediated	NULL
Suppression	NULL
of	NULL
the	NULL
Insulin	NULL
Gene	NULL
Promoter	NULL
Activity	NULL
in	NULL
HIT	NULL
Cells	NULL
Taka-aki	NULL
Matsuoka	NULL
,	NULL
*	NULL
Yoshitaka	NULL
Kajimoto	NULL
,	NULL
*	NULL
Hirotaka	NULL
Watada	NULL
,	NULL
*	NULL
Hideaki	NULL
Kaneto	NULL
,	NULL
*	NULL
Michihiko	NULL
Kishimoto	NULL
,	NULL
*	NULL
Yutaka	NULL
Umayahara	NULL
,	NULL
*	NULL
Yoshio	NULL
Fujitani	NULL
,	NULL
*	NULL
Takenobu	NULL
Kamada	NULL
,	NULL
*	NULL
Ryuzo	NULL
Kawamori	NULL
,	NULL
and	NULL
Yoshimitsu	NULL
Yamasaki*	NULL
*First	NULL
Department	NULL
of	NULL
Medicine	NULL
,	NULL
Osaka	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
Suita	NULL
565	NULL
;	NULL
and	NULL
*Department	NULL
of	NULL
Medicine	NULL
,	NULL
Endocrinology	NULL
and	NULL
Metabolism	NULL
,	NULL
Juntendo	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
Tokyo	NULL
113	NULL
,	NULL
Japan	NULL
Abstract	NULL
Prolonged	NULL
poor	NULL
glycemic	NULL
control	NULL
in	NULL
non-insulin-dependent	NULL
diabetes	NULL
mellitus	NULL
patients	NULL
often	NULL
leads	NULL
to	NULL
a	NULL
decline	NULL
in	NULL
insulin	NULL
secretion	NULL
from	NULL
pancreatic	NULL
B	NULL
cells	NULL
,	NULL
accompanied	NULL
by	NULL
a	NULL
decrease	NULL
in	NULL
the	NULL
insulin	NULL
content	NULL
of	NULL
the	NULL
cells	NULL
.	NULL

As	NULL
a	NULL
step	NULL
toward	NULL
elucidating	NULL
the	NULL
pathophysiological	NULL
background	NULL
of	NULL
the	NULL
so-called	NULL
glucose	NULL
toxicity	NULL
to	NULL
pancreatic	NULL
B	NULL
cells	NULL
,	NULL
we	NULL
induced	NULL
glycation	NULL
in	NULL
HIT-T15	NULL
cells	NULL
using	NULL
a	NULL
sugar	NULL
with	NULL
strong	NULL
deoxidizing	NULL
activity	NULL
,	NULL
D-ribose	NULL
,	NULL
and	NULL
examined	NULL
the	NULL
effects	NULL
on	NULL
insulin	NULL
gene	NULL
transcription	NULL
.	NULL

The	NULL
results	NULL
of	NULL
reporter	NULL
gene	NULL
analyses	NULL
revealed	NULL
that	NULL
the	NULL
insulin	NULL
gene	NULL
promoter	NULL
is	NULL
more	NULL
sensitive	NULL
to	NULL
glycation	NULL
than	NULL
the	NULL
control	NULL
B-actin	NULL
gene	NULL
promoter	NULL
;	NULL
~	NULL
50	NULL
and	NULL
80	NULL
%	NULL
of	NULL
the	NULL
insulin	NULL
gene	NULL
promoter	NULL
activity	NULL
was	NULL
lost	NULL
when	NULL
the	NULL
cells	NULL
were	NULL
kept	NULL
for	NULL
3	NULL
d	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
40	NULL
and	NULL
60	NULL
mM	NULL
D-ribose	NULL
,	NULL
respectively	NULL
.	NULL

In	NULL
agreement	NULL
with	NULL
this	NULL
,	NULL
decrease	NULL
in	NULL
the	NULL
insulin	NULL
mRNA	NULL
and	NULL
insulin	NULL
content	NULL
was	NULL
observed	NULL
in	NULL
the	NULL
glycation-induced	NULL
cells	NULL
.	NULL

Also	NULL
,	NULL
gel	NULL
mobility	NULL
shift	NULL
analyses	NULL
using	NULL
specific	NULL
antiserum	NULL
revealed	NULL
decrease	NULL
in	NULL
the	NULL
DNA-binding	NULL
activity	NULL
of	NULL
an	NULL
insulin	NULL
gene	NULL
transcription	NULL
factor	NULL
,	NULL
PDX-1/IPF1/STF-1	NULL
.	NULL

These	NULL
effects	NULL
of	NULL
D-ribose	NULL
seemed	NULL
almost	NULL
irreversible	NULL
but	NULL
could	NULL
be	NULL
prevented	NULL
by	NULL
addition	NULL
of	NULL
1	NULL
mM	NULL
aminoguanidine	NULL
or	NULL
10	NULL
mM	NULL
N-acetylcysteine	NULL
,	NULL
thus	NULL
suggesting	NULL
that	NULL
glycation	NULL
and	NULL
reactive	NULL
oxygen	NULL
species	NULL
,	NULL
generated	NULL
through	NULL
the	NULL
glycation	NULL
reaction	NULL
,	NULL
serve	NULL
as	NULL
mediators	NULL
of	NULL
the	NULL
phenomena	NULL
.	NULL

These	NULL
observations	NULL
suggest	NULL
that	NULL
protein	NULL
glycation	NULL
in	NULL
pancreatic	NULL
B	NULL
cells	NULL
,	NULL
which	NULL
occurs	NULL
in	NULL
vivo	NULL
under	NULL
chronic	NULL
hyperglycemia	NULL
,	NULL
suppresses	NULL
insulin	NULL
gene	NULL
transcription	NULL
and	NULL
thus	NULL
can	NULL
explain	NULL
part	NULL
of	NULL
the	NULL
B	NULL
cell	NULL
glucose	NULL
toxicity	NULL
.	NULL

(	NULL
J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

1997	NULL
.	NULL

99:144-150	NULL
.	NULL
)	NULL

Key	NULL
words	NULL
:	NULL
gene	NULL
expression	NULL
regulation	NULL
«	NULL
transcription	NULL
factors	NULL
«	NULL
glycosylation	NULL
«	NULL
homeodomain	NULL
protein	NULL
«	NULL
oxidative	NULL
stress	NULL
Introduction	NULL
Although	NULL
glucose	NULL
is	NULL
the	NULL
major	NULL
physiologic	NULL
stimulator	NULL
of	NULL
insulin	NULL
secretion	NULL
and	NULL
biosynthesis	NULL
in	NULL
vivo	NULL
,	NULL
prolonged	NULL
exposure	NULL
of	NULL
pancreatic	NULL
B	NULL
cells	NULL
to	NULL
high	NULL
glucose	NULL
levels	NULL
is	NULL
known	NULL
to	NULL
cause	NULL
B	NULL
cell	NULL
dysfunction	NULL
(	NULL
1	NULL
,	NULL
2	NULL
)	NULL
.	NULL

Histologically	NULL
,	NULL
such	NULL
damaged	NULL
B	NULL
cells	NULL
often	NULL
Address	NULL
correspondence	NULL
to	NULL
Dr.	NULL
Yoshitaka	NULL
Kajimoto	NULL
,	NULL
First	NULL
Department	NULL
of	NULL
Medicine	NULL
,	NULL
Osaka	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
2-2	NULL
Ya-madaoka	NULL
,	NULL
Suita	NULL
City	NULL
,	NULL
Osaka	NULL
Pref	NULL
.	NULL

565	NULL
,	NULL
Japan	NULL
.	NULL

Phone	NULL
:	NULL
81-6-879-3633	NULL
;	NULL
FAX	NULL
:	NULL
81-6-879-3639	NULL
.	NULL

Received	NULL
for	NULL
publication	NULL
5	NULL
August	NULL
1996	NULL
and	NULL
accepted	NULL
in	NULL
revised	NULL
form	NULL
22	NULL
October	NULL
1996	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

©	NULL
The	NULL
American	NULL
Society	NULL
for	NULL
Clinical	NULL
Investigation	NULL
,	NULL
Inc.	NULL
0021-9738/97/01/0144/07	NULL
-	NULL
$	NULL
2.00	NULL
Volume	NULL
99	NULL
,	NULL
Number	NULL
1	NULL
,	NULL
January	NULL
1997	NULL
,	NULL
144-150	NULL
144	NULL
Matsuoka	NULL
et	NULL
al	NULL
.	NULL

reveal	NULL
extensive	NULL
degranulation	NULL
,	NULL
thus	NULL
suggesting	NULL
impaired	NULL
insulin	NULL
biosynthesis	NULL
as	NULL
a	NULL
cause	NULL
of	NULL
the	NULL
phenomenon	NULL
(	NULL
3	NULL
)	NULL
.	NULL

The	NULL
clinical	NULL
significance	NULL
of	NULL
this	NULL
phenomenon	NULL
is	NULL
supported	NULL
by	NULL
the	NULL
association	NULL
between	NULL
the	NULL
development	NULL
of	NULL
diabetes	NULL
and	NULL
the	NULL
substantial	NULL
reduction	NULL
of	NULL
insulin	NULL
content	NULL
in	NULL
B	NULL
cells	NULL
in	NULL
model	NULL
animals	NULL
with	NULL
non-insulin-dependent	NULL
diabetes	NULL
mellitus	NULL
(	NULL
NIDDM	NULL
)	NULL
!	NULL

(	NULL
4	NULL
,	NULL
5	NULL
)	NULL
.	NULL

Despite	NULL
the	NULL
fact	NULL
that	NULL
glucose	NULL
toxicity	NULL
has	NULL
long	NULL
been	NULL
a	NULL
well-recognized	NULL
clinical	NULL
concept	NULL
,	NULL
its	NULL
biochemical	NULL
background	NULL
is	NULL
poorly	NULL
understood	NULL
.	NULL

While	NULL
technical	NULL
difficulties	NULL
have	NULL
prevented	NULL
extensive	NULL
in	NULL
vivo	NULL
research	NULL
,	NULL
a	NULL
line	NULL
of	NULL
in	NULL
vitro	NULL
studies	NULL
using	NULL
B	NULL
cell-derived	NULL
HIT-T15	NULL
cells	NULL
that	NULL
were	NULL
kept	NULL
under	NULL
high	NULL
glucose	NULL
conditions	NULL
for	NULL
a	NULL
very	NULL
long	NULL
period	NULL
(	NULL
>	NULL
25	NULL
passages	NULL
)	NULL
has	NULL
provided	NULL
useful	NULL
information	NULL
as	NULL
to	NULL
the	NULL
possible	NULL
mechanisms	NULL
underlying	NULL
the	NULL
decrease	NULL
in	NULL
insulin	NULL
biosynthesis	NULL
(	NULL
6-9	NULL
)	NULL
.	NULL

According	NULL
to	NULL
the	NULL
results	NULL
of	NULL
those	NULL
studies	NULL
,	NULL
long-term	NULL
exposure	NULL
to	NULL
high	NULL
glucose	NULL
concentration	NULL
caused	NULL
the	NULL
HIT-T15	NULL
cells	NULL
to	NULL
suppress	NULL
insulin	NULL
gene	NULL
promoter	NULL
activity	NULL
,	NULL
and	NULL
led	NULL
to	NULL
decreases	NULL
in	NULL
insulin	NULL
mRNA	NULL
amount	NULL
,	NULL
insulin	NULL
content	NULL
,	NULL
and	NULL
capacity	NULL
for	NULL
insulin	NULL
secretion	NULL
.	NULL

These	NULL
observations	NULL
support	NULL
the	NULL
idea	NULL
that	NULL
reduction	NULL
of	NULL
the	NULL
promoter	NULL
activity	NULL
may	NULL
play	NULL
a	NULL
primary	NULL
role	NULL
in	NULL
the	NULL
impairment	NULL
of	NULL
insulin	NULL
biosynthesis	NULL
and	NULL
suggest	NULL
the	NULL
potential	NULL
usefulness	NULL
of	NULL
such	NULL
in	NULL
vitro	NULL
systems	NULL
for	NULL
the	NULL
study	NULL
of	NULL
the	NULL
molecular	NULL
aspects	NULL
of	NULL
B	NULL
cell	NULL
glucose	NULL
toxicity	NULL
.	NULL

To	NULL
enable	NULL
effective	NULL
prevention	NULL
and	NULL
treatment	NULL
of	NULL
glucose	NULL
toxicity	NULL
to	NULL
B	NULL
cells	NULL
,	NULL
it	NULL
would	NULL
be	NULL
essential	NULL
to	NULL
understand	NULL
the	NULL
biochemical	NULL
aspects	NULL
of	NULL
the	NULL
phenomenon	NULL
.	NULL

In	NULL
terms	NULL
of	NULL
glucose-induced	NULL
cell	NULL
damage	NULL
,	NULL
several	NULL
possible	NULL
mechanisms	NULL
have	NULL
been	NULL
proposed	NULL
to	NULL
date	NULL
,	NULL
including	NULL
increased	NULL
osmolarity	NULL
,	NULL
an	NULL
activated	NULL
sorbitol	NULL
pathway	NULL
,	NULL
and	NULL
an	NULL
activated	NULL
glycation	NULL
reaction	NULL
(	NULL
10	NULL
,	NULL
11	NULL
)	NULL
.	NULL

Among	NULL
them	NULL
,	NULL
glycation	NULL
seems	NULL
to	NULL
have	NULL
broad	NULL
pathological	NULL
sig-nificance	NULL
:	NULL
various	NULL
glycated	NULL
proteins	NULL
such	NULL
as	NULL
glycosylated	NULL
hemo-globin	NULL
,	NULL
albumin	NULL
,	NULL
and	NULL
lens	NULL
crystalline	NULL
are	NULL
nonenzymatically	NULL
produced	NULL
through	NULL
the	NULL
Maillard	NULL
reaction	NULL
(	NULL
12-14	NULL
)	NULL
.	NULL

These	NULL
can	NULL
be	NULL
observed	NULL
even	NULL
under	NULL
physiological	NULL
conditions	NULL
in	NULL
vivo	NULL
,	NULL
but	NULL
they	NULL
increase	NULL
under	NULL
hyperglycemic	NULL
conditions	NULL
(	NULL
12	NULL
,	NULL
13	NULL
,	NULL
15	NULL
)	NULL
.	NULL

In	NULL
diabetic	NULL
animals	NULL
,	NULL
glycation	NULL
is	NULL
observed	NULL
extensively	NULL
in	NULL
various	NULL
organs	NULL
and	NULL
tissues	NULL
including	NULL
the	NULL
kidney	NULL
,	NULL
liver	NULL
,	NULL
brain	NULL
,	NULL
and	NULL
lung	NULL
(	NULL
12	NULL
,	NULL
16	NULL
)	NULL
.	NULL

During	NULL
the	NULL
Maillard	NULL
reaction	NULL
,	NULL
which	NULL
in	NULL
turn	NULL
produces	NULL
Schiff	NULL
base	NULL
,	NULL
Amadori	NULL
product	NULL
and	NULL
advanced	NULL
glycosylation	NULL
end	NULL
products	NULL
(	NULL
AGE	NULL
)	NULL
,	NULL
reactive	NULL
oxygen	NULL
species	NULL
(	NULL
ROS	NULL
)	NULL
are	NULL
also	NULL
pro-duced	NULL
,	NULL
and	NULL
this	NULL
is	NULL
suggested	NULL
to	NULL
be	NULL
involved	NULL
in	NULL
tissue	NULL
damage	NULL
(	NULL
17	NULL
,	NULL
18	NULL
)	NULL
.	NULL

In	NULL
the	NULL
present	NULL
study	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
possible	NULL
effects	NULL
of	NULL
glycation	NULL
on	NULL
insulin	NULL
gene	NULL
transcription	NULL
using	NULL
a	NULL
sugar	NULL
with	NULL
powerful	NULL
reducing	NULL
activity	NULL
,	NULL
D-ribose	NULL
(	NULL
19	NULL
,	NULL
20	NULL
)	NULL
.	NULL

Co-use	NULL
of	NULL
aminoguanidine	NULL
,	NULL
which	NULL
binds	NULL
to	NULL
the	NULL
Amadori	NULL
product	NULL
or	NULL
3-deoxy-	NULL
1	NULL
.	NULL

Abbreviations	NULL
used	NULL
in	NULL
this	NULL
paper	NULL
:	NULL
AGE	NULL
,	NULL
advanced	NULL
glycosylation	NULL
end	NULL
products	NULL
;	NULL
NAC	NULL
,	NULL
N-acetylcysteine	NULL
;	NULL
NIDDM	NULL
,	NULL
non-insulin-dependent	NULL
diabetes	NULL
mellitus	NULL
;	NULL
ROS	NULL
,	NULL
reactive	NULL
oxygen	NULL
species	NULL
;	NULL
RSV-LTR	NULL
,	NULL
Rous	NULL
sarcoma	NULL
virus	NULL
long	NULL
terminal	NULL
repeat	NULL
.	NULL

glucosone	NULL
and	NULL
inhibits	NULL
the	NULL
glycation	NULL
reaction	NULL
(	NULL
21	NULL
,	NULL
22	NULL
)	NULL
,	NULL
and	NULL
N-acetylcysteine	NULL
(	NULL
NAC	NULL
)	NULL
,	NULL
an	NULL
antioxidant	NULL
(	NULL
23	NULL
,	NULL
24	NULL
)	NULL
,	NULL
allowed	NULL
us	NULL
to	NULL
show	NULL
that	NULL
glycation	NULL
and	NULL
the	NULL
consequent	NULL
increase	NULL
of	NULL
ROS	NULL
are	NULL
potential	NULL
suppressors	NULL
of	NULL
the	NULL
insulin	NULL
gene	NULL
promoter	NULL
.	NULL

Significant	NULL
reduction	NULL
of	NULL
the	NULL
DNA-binding	NULL
activity	NULL
of	NULL
a	NULL
transcription	NULL
factor	NULL
,	NULL
PDX-1/IPF1/STF-1	NULL
(	NULL
25	NULL
,	NULL
26	NULL
)	NULL
,	NULL
was	NULL
also	NULL
observed	NULL
in	NULL
glycation-induced	NULL
cells	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
high	NULL
sensitivity	NULL
of	NULL
the	NULL
insulin	NULL
gene	NULL
transcription	NULL
factors	NULL
to	NULL
glycation	NULL
or	NULL
ROS	NULL
may	NULL
underlie	NULL
the	NULL
suppression	NULL
of	NULL
the	NULL
insulin	NULL
gene	NULL
promoter	NULL
activity	NULL
.	NULL

Methods	NULL
Materials	NULL
.	NULL

Restriction	NULL
enzymes	NULL
,	NULL
DNA	NULL
polymerases	NULL
,	NULL
and	NULL
other	NULL
modification	NULL
enzymes	NULL
were	NULL
purchased	NULL
from	NULL
commercial	NULL
suppliers	NULL
(	NULL
Toy-obo	NULL
,	NULL
Tokyo	NULL
,	NULL
Japan	NULL
;	NULL
Takara	NULL
,	NULL
Kyoto	NULL
,	NULL
Japan	NULL
;	NULL
Stratagene	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
;	NULL
Promega	NULL
Biotec	NULL
,	NULL
Madison	NULL
,	NULL
WI	NULL
;	NULL
New	NULL
England	NULL
Biolabs	NULL
,	NULL
Beverly	NULL
,	NULL
MA	NULL
)	NULL
,	NULL
and	NULL
radioisotopes	NULL
were	NULL
from	NULL
Amersham	NULL
Japan	NULL
(	NULL
Tokyo	NULL
,	NULL
Japan	NULL
)	NULL
.	NULL

Tissue	NULL
culture	NULL
media	NULL
were	NULL
purchased	NULL
from	NULL
Nakalai	NULL
Tesque	NULL
(	NULL
Tokyo	NULL
,	NULL
Japan	NULL
)	NULL
,	NULL
and	NULL
FBS	NULL
was	NULL
from	NULL
ICN	NULL
Biomedicals	NULL
,	NULL
Inc.	NULL
(	NULL
Costa	NULL
Mesa	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Oligonucleotides	NULL
were	NULL
synthesized	NULL
with	NULL
a	NULL
DNA/RNA	NULL
synthesizer	NULL
(	NULL
model	NULL
394	NULL
;	NULL
Applied	NULL
Biosystems	NULL
,	NULL
Tokyo	NULL
,	NULL
Japan	NULL
)	NULL
.	NULL

Basic	NULL
laboratory	NULL
procedures	NULL
were	NULL
performed	NULL
according	NULL
to	NULL
standard	NULL
protocols	NULL
(	NULL
27	NULL
)	NULL
,	NULL
unless	NULL
otherwise	NULL
stated	NULL
.	NULL

Cell	NULL
culture	NULL
and	NULL
gene	NULL
transfer	NULL
studies	NULL
.	NULL

B	NULL
cell-derived	NULL
cell	NULL
line	NULL
HIT-T15	NULL
cells	NULL
(	NULL
No	NULL
.	NULL

1777	NULL
;	NULL
American	NULL
Type	NULL
Culture	NULL
Collection	NULL
,	NULL
Rockville	NULL
,	NULL
MD	NULL
)	NULL
were	NULL
grown	NULL
in	NULL
RPMI-1640	NULL
medium	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
heat-inactivated	NULL
FBS	NULL
,	NULL
penicillin	NULL
and	NULL
streptomycin	NULL
.	NULL

The	NULL
HIT-T15	NULL
cells	NULL
used	NULL
in	NULL
this	NULL
study	NULL
were	NULL
passage	NULL
70-75	NULL
,	NULL
and	NULL
they	NULL
retained	NULL
glucose-responsive	NULL
insulin	NULL
gene	NULL
transcription	NULL
and	NULL
secretion	NULL
.	NULL

The	NULL
plasmids	NULL
used	NULL
in	NULL
reporter	NULL
gene	NULL
analyses	NULL
were	NULL
pA3RSVLuc	NULL
(	NULL
28	NULL
)	NULL
,	NULL
containing	NULL
the	NULL
Rous	NULL
sarcoma	NULL
virus	NULL
long	NULL
terminal	NULL
repeat	NULL
(	NULL
RSV-LTR	NULL
)	NULL
,	NULL
pHBLuc	NULL
(	NULL
29	NULL
)	NULL
,	NULL
containing	NULL
the	NULL
4.3-kb	NULL
fragment	NULL
of	NULL
the	NULL
human	NULL
B-actin	NULL
gene	NULL
promoter	NULL
,	NULL
and	NULL
pA3InsLuc	NULL
(	NULL
30	NULL
)	NULL
,	NULL
containing	NULL
326-bp	NULL
5'-flanking	NULL
sequences	NULL
of	NULL
human	NULL
insulin	NULL
gene	NULL
.	NULL

pA3RSVLuc	NULL
was	NULL
a	NULL
generous	NULL
gift	NULL
from	NULL
Drs	NULL
.	NULL

W.M	NULL
.	NULL

Wood	NULL
(	NULL
University	NULL
of	NULL
Colorado	NULL
Health	NULL
Science	NULL
Center	NULL
,	NULL
Denver	NULL
,	NULL
CO	NULL
)	NULL
and	NULL
D.R	NULL
.	NULL

Helinski	NULL
(	NULL
University	NULL
of	NULL
California	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
,	NULL
and	NULL
pHBLuc	NULL
was	NULL
from	NULL
Drs	NULL
.	NULL

M.A	NULL
.	NULL

Barry	NULL
and	NULL
S.A.	NULL
Johnston	NULL
(	NULL
University	NULL
of	NULL
Texas	NULL
Southwestern	NULL
Medical	NULL
Center	NULL
,	NULL
Dallas	NULL
,	NULL
TX	NULL
)	NULL
.	NULL

24	NULL
h	NULL
before	NULL
gene	NULL
transfection	NULL
,	NULL
HIT-T15	NULL
cells	NULL
were	NULL
replated	NULL
in	NULL
six-well	NULL
tissue	NULL
culture	NULL
plates	NULL
.	NULL

1	NULL
g	NULL
of	NULL
each	NULL
reporter	NULL
plasmid	NULL
was	NULL
transfected	NULL
into	NULL
the	NULL
cells	NULL
by	NULL
the	NULL
lipofection	NULL
method	NULL
using	NULL
LipofectAMINE	NULL
``	NULL
reagent	NULL
(	NULL
Life	NULL
Tech-nologies	NULL
,	NULL
Tokyo	NULL
,	NULL
Japan	NULL
)	NULL
under	NULL
the	NULL
conditions	NULL
recommended	NULL
by	NULL
the	NULL
manufacturer	NULL
.	NULL

For	NULL
evaluation	NULL
of	NULL
promoter	NULL
activities	NULL
,	NULL
HIT-T15	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
the	NULL
pA3InsLuc	NULL
,	NULL
pHBLuc	NULL
,	NULL
or	NULL
pA3RSVLuc	NULL
plasmid	NULL
and	NULL
grown	NULL
for	NULL
78	NULL
h	NULL
,	NULL
followed	NULL
by	NULL
harvest	NULL
of	NULL
cell	NULL
lysates	NULL
and	NULL
luciferase	NULL
assays	NULL
.	NULL

When	NULL
required	NULL
,	NULL
40	NULL
or	NULL
60	NULL
mM	NULL
D-ribose	NULL
was	NULL
added	NULL
to	NULL
the	NULL
media	NULL
6	NULL
h	NULL
after	NULL
transfection	NULL
.	NULL

In	NULL
some	NULL
of	NULL
the	NULL
experiments	NULL
,	NULL
1	NULL
mM	NULL
aminoguanidine	NULL
or	NULL
10	NULL
mM	NULL
NAC	NULL
was	NULL
also	NULL
added	NULL
.	NULL

Luciferase	NULL
activities	NULL
were	NULL
normalized	NULL
with	NULL
respect	NULL
to	NULL
protein	NULL
concentrations	NULL
of	NULL
the	NULL
cell	NULL
lysates	NULL
,	NULL
and	NULL
the	NULL
results	NULL
were	NULL
presented	NULL
as	NULL
relative	NULL
luciferase	NULL
activity	NULL
with	NULL
that	NULL
in	NULL
D-ribose-untreated	NULL
HIT	NULL
cells	NULL
arbitrarily	NULL
set	NULL
at	NULL
100	NULL
%	NULL
.	NULL

Northern	NULL
blot	NULL
analyses	NULL
of	NULL
insulin	NULL
mRNA	NULL
.	NULL

Northern	NULL
blots	NULL
followed	NULL
standard	NULL
procedures	NULL
(	NULL
27	NULL
)	NULL
using	NULL
10	NULL
pg	NULL
total	NULL
RNA	NULL
.	NULL

Total	NULL
RNA	NULL
was	NULL
isolated	NULL
from	NULL
HIT-T15	NULL
cells	NULL
that	NULL
had	NULL
been	NULL
kept	NULL
for	NULL
5	NULL
d	NULL
under	NULL
0	NULL
,	NULL
40	NULL
,	NULL
or	NULL
60	NULL
mM	NULL
D-ribose	NULL
with	NULL
or	NULL
without	NULL
addition	NULL
of	NULL
1	NULL
mM	NULL
aminoguanidine	NULL
or	NULL
10	NULL
mM	NULL
NAC	NULL
.	NULL

For	NULL
the	NULL
purpose	NULL
of	NULL
examining	NULL
the	NULL
reversibility	NULL
of	NULL
the	NULL
D-ribose	NULL
effects	NULL
on	NULL
the	NULL
cells	NULL
,	NULL
HIT-T15	NULL
cells	NULL
were	NULL
kept	NULL
for	NULL
5	NULL
d	NULL
under	NULL
40	NULL
mM	NULL
D-ribose	NULL
and	NULL
then	NULL
without	NULL
D-ribose	NULL
for	NULL
2	NULL
or	NULL
5	NULL
d.	NULL
The	NULL
hybridiza-tion	NULL
probe	NULL
was	NULL
a	NULL
408-bp	NULL
mouse	NULL
insulin	NULL
II	NULL
cDNA	NULL
isolated	NULL
from	NULL
the	NULL
plasmid	NULL
pMIn2C	NULL
(	NULL
31	NULL
)	NULL
and	NULL
was	NULL
a	NULL
kind	NULL
gift	NULL
from	NULL
Drs	NULL
.	NULL

J.M	NULL
.	NULL

Chirgwin	NULL
(	NULL
University	NULL
of	NULL
Texas	NULL
Health	NULL
Science	NULL
Center	NULL
,	NULL
San	NULL
Antonio	NULL
,	NULL
TX	NULL
)	NULL
and	NULL
M.A	NULL
.	NULL

Permutt	NULL
(	NULL
Washington	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
St.	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
.	NULL

Insulin	NULL
content	NULL
determination	NULL
.	NULL

HIT-T15	NULL
cells	NULL
that	NULL
had	NULL
been	NULL
kept	NULL
for	NULL
5	NULL
d	NULL
under	NULL
0	NULL
or	NULL
40	NULL
mM	NULL
D-ribose	NULL
were	NULL
harvested	NULL
and	NULL
extracted	NULL
for	NULL
24	NULL
h	NULL
at	NULL
4°C	NULL
in	NULL
acid-ethanol	NULL
.	NULL

Insulin	NULL
in	NULL
the	NULL
extracts	NULL
was	NULL
assayed	NULL
by	NULL
ra	NULL
dioimmunoassay	NULL
using	NULL
a	NULL
rodent	NULL
insulin	NULL
as	NULL
a	NULL
standard	NULL
.	NULL

Total	NULL
protein	NULL
in	NULL
the	NULL
extracts	NULL
was	NULL
measured	NULL
using	NULL
a	NULL
protein	NULL
assay	NULL
(	NULL
Bio	NULL
Rad	NULL
Laborato-ries	NULL
,	NULL
Richmond	NULL
,	NULL
CA	NULL
)	NULL
and	NULL
the	NULL
BSA	NULL
standard	NULL
.	NULL

Insulin	NULL
concentration	NULL
was	NULL
normalized	NULL
with	NULL
respect	NULL
to	NULL
protein	NULL
concentration	NULL
.	NULL

Preparation	NULL
of	NULL
nuclear	NULL
extracts	NULL
and	NULL
gel	NULL
mobility	NULL
shift	NULL
analyses	NULL
.	NULL

Following	NULL
the	NULL
procedure	NULL
described	NULL
by	NULL
Sadowski	NULL
and	NULL
Gilman	NULL
(	NULL
32	NULL
)	NULL
,	NULL
nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
HIT-T15	NULL
cells	NULL
kept	NULL
for	NULL
5	NULL
d	NULL
in	NULL
media	NULL
containing	NULL
0	NULL
,	NULL
40	NULL
,	NULL
or	NULL
60	NULL
mM	NULL
D-ribose	NULL
with	NULL
or	NULL
without	NULL
the	NULL
addition	NULL
of	NULL
1	NULL
mM	NULL
aminoguanidine	NULL
or	NULL
10	NULL
mM	NULL
NAC	NULL
.	NULL

For	NULL
the	NULL
purpose	NULL
of	NULL
examining	NULL
the	NULL
reversibility	NULL
of	NULL
the	NULL
-ribose	NULL
effects	NULL
on	NULL
the	NULL
cells	NULL
,	NULL
HIT-T15	NULL
cells	NULL
were	NULL
kept	NULL
for	NULL
5	NULL
d	NULL
under	NULL
40	NULL
mM	NULL
D-ribose	NULL
and	NULL
then	NULL
without	NULL
D-ribose	NULL
for	NULL
2	NULL
or	NULL
5	NULL
d.	NULL
3	NULL
g	NULL
of	NULL
each	NULL
nuclear	NULL
extract	NULL
was	NULL
preincubated	NULL
with	NULL
1	NULL
g	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
at	NULL
4°C	NULL
in	NULL
a	NULL
20-pl	NULL
reaction	NULL
mixture	NULL
containing	NULL
20	NULL
mM	NULL
Hepes	NULL
,	NULL
pH	NULL
7.9	NULL
,	NULL
150	NULL
mM	NULL
NaCl	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
1	NULL
mM	NULL
DTT	NULL
and	NULL
3	NULL
%	NULL
Ficoll	NULL
(	NULL
vol/vol	NULL
)	NULL
.	NULL

15	NULL
min	NULL
later	NULL
,	NULL
the	NULL
binding	NULL
reaction	NULL
was	NULL
initiated	NULL
by	NULL
adding	NULL
100	NULL
pg	NULL
(	NULL
~	NULL
10*	NULL
cpm	NULL
)	NULL
of	NULL
5	NULL
'	NULL
end	NULL
P-labeled	NULL
oligonucleotide	NULL
probes	NULL
and	NULL
,	NULL
when	NULL
required	NULL
,	NULL
nonradioactive	NULL
competitor	NULL
double-stranded	NULL
oligonucleotides	NULL
were	NULL
added	NULL
,	NULL
followed	NULL
by	NULL
incubation	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
30	NULL
min	NULL
.	NULL

When	NULL
required	NULL
,	NULL
2	NULL
pl	NULL
of	NULL
preimmune	NULL
serum	NULL
or	NULL
anti-PDX-1	NULL
(	NULL
IPF1	NULL
)	NULL
antiserum	NULL
was	NULL
added	NULL
to	NULL
the	NULL
binding	NULL
reaction	NULL
mixtures	NULL
and	NULL
these	NULL
were	NULL
kept	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
30	NULL
min	NULL
before	NULL
addition	NULL
of	NULL
the	NULL
binding	NULL
probes	NULL
.	NULL

The	NULL
samples	NULL
were	NULL
fractionated	NULL
on	NULL
5	NULL
%	NULL
PAGE	NULL
precooled	NULL
to	NULL
4°C	NULL
in	NULL
0.5	NULL
x	NULL
TBE	NULL
(	NULL
45	NULL
mM	NULL
Tris	NULL
base	NULL
,	NULL
45	NULL
mM	NULL
borie	NULL
acid	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
)	NULL
.	NULL

Results	NULL
Sensitivity	NULL
of	NULL
insulin	NULL
gene	NULL
promoter	NULL
to	NULL
glycation	NULL
.	NULL

To	NULL
evaluate	NULL
the	NULL
effects	NULL
of	NULL
glycation	NULL
on	NULL
insulin	NULL
gene	NULL
transcription	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
insulin	NULL
gene	NULL
promoter	NULL
activity	NULL
in	NULL
HIT-T15	NULL
cells	NULL
that	NULL
had	NULL
been	NULL
treated	NULL
with	NULL
a	NULL
sugar	NULL
with	NULL
strong	NULL
reducing	NULL
activity	NULL
,	NULL
D-ribose	NULL
.	NULL

Three	NULL
kinds	NULL
of	NULL
fusion	NULL
gene	NULL
plasmids	NULL
,	NULL
which	NULL
contained	NULL
the	NULL
luciferase	NULL
reporter	NULL
linked	NULL
to	NULL
the	NULL
human	NULL
insulin	NULL
gene	NULL
promoter	NULL
,	NULL
human	NULL
B-actin	NULL
gene	NULL
promoter	NULL
or	NULL
RSV-LTR	NULL
promoter	NULL
,	NULL
were	NULL
individually	NULL
transfected	NULL
into	NULL
the	NULL
HIT-T15	NULL
cells	NULL
.	NULL

The	NULL
transfected	NULL
cells	NULL
were	NULL
kept	NULL
for	NULL
72	NULL
h	NULL
with	NULL
or	NULL
without	NULL
D-ribose	NULL
and	NULL
were	NULL
then	NULL
harvested	NULL
for	NULL
luciferase	NULL
assays	NULL
.	NULL

The	NULL
results	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
A	NULL
and	NULL
Table	NULL
I	NULL
indicated	NULL
that	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
insulin	NULL
gene	NULL
promoter	NULL
was	NULL
suppressed	NULL
down	NULL
to	NULL
48+19	NULL
and	NULL
18+6	NULL
%	NULL
of	NULL
A	NULL
B	NULL
C	NULL
>	NULL
(	NULL
%	NULL
)	NULL
(	NULL
%	NULL
)	NULL
(	NULL
%	NULL
)	NULL
€	NULL
150	NULL
150	NULL
300	NULL
gs	NULL
<	NULL
4	NULL
®	NULL
@	NULL
100	NULL
100	NULL
200	NULL
$	NULL
3	NULL
4	NULL
g	NULL
50	NULL
50	NULL
100	NULL
2	NULL
s	NULL
@	NULL
tc	NULL
D-Ribose	NULL
_	NULL
q	NULL
4p	NULL
60	NULL
0	NULL
40	NULL
60	NULL
0	NULL
40	NULL
60	NULL
{	NULL
mM	NULL
)	NULL
Figure	NULL
1	NULL
.	NULL

Effects	NULL
of	NULL
D-ribose	NULL
on	NULL
the	NULL
insulin	NULL
gene	NULL
promoter	NULL
activity	NULL
.	NULL

A	NULL
reporter	NULL
gene	NULL
plasmid	NULL
containing	NULL
(	NULL
A	NULL
)	NULL
human	NULL
insulin	NULL
gene	NULL
promoter	NULL
(	NULL
30	NULL
)	NULL
,	NULL
(	NULL
B	NULL
)	NULL
human	NULL
B-actin	NULL
gene	NULL
promoter	NULL
(	NULL
29	NULL
)	NULL
,	NULL
or	NULL
(	NULL
C	NULL
)	NULL
RSV-LTR	NULL
promoter	NULL
(	NULL
28	NULL
)	NULL
was	NULL
transfected	NULL
into	NULL
HIT-T15	NULL
cells	NULL
.	NULL

6	NULL
h	NULL
after	NULL
the	NULL
transfection	NULL
,	NULL
40	NULL
or	NULL
60	NULL
mM	NULL
D-ribose	NULL
or	NULL
vehicle	NULL
only	NULL
(	NULL
0	NULL
mM	NULL
)	NULL
was	NULL
added	NULL
to	NULL
the	NULL
medium	NULL
and	NULL
the	NULL
cells	NULL
were	NULL
cultured	NULL
for	NULL
an	NULL
additional	NULL
72	NULL
h	NULL
,	NULL
followed	NULL
by	NULL
harvest	NULL
of	NULL
cell	NULL
lysates	NULL
,	NULL
which	NULL
were	NULL
then	NULL
subjected	NULL
to	NULL
luciferase	NULL
assays	NULL
.	NULL

Results	NULL
are	NULL
presented	NULL
as	NULL
relative	NULL
luciferase	NULL
activity	NULL
with	NULL
that	NULL
in	NULL
D-ribose-untreated	NULL
(	NULL
0	NULL
mM	NULL
)	NULL
HIT	NULL
cells	NULL
arbitrarily	NULL
set	NULL
at	NULL
100	NULL
%	NULL
.	NULL

All	NULL
data	NULL
are	NULL
presented	NULL
as	NULL
means+SD	NULL
of	NULL
at	NULL
least	NULL
four	NULL
individual	NULL
experiments	NULL
.	NULL

Glycation	NULL
Suppresses	NULL
Insulin	NULL
Gene	NULL
Promoter	NULL
Activity	NULL
145	NULL
Table	NULL
I	NULL
.	NULL

Relative	NULL
Promoter	NULL
Activity	NULL
in	NULL
Various	NULL
Culture	NULL
Condition	NULL
Relative	NULL
luciferase	NULL
activity	NULL
(	NULL
%	NULL
)	NULL
Medium	NULL
condition	NULL
Insulin	NULL
B-Actin	NULL
RSV-LTV	NULL
0	NULL
mM	NULL
p-ribose	NULL
100	NULL
100	NULL
100	NULL
40	NULL
mM	NULL
D-ribose	NULL
48+19	NULL
112+12	NULL
252460	NULL
60	NULL
mM	NULL
D-ribose	NULL
18+6	NULL
87+14	NULL
258495	NULL
40	NULL
mM	NULL
D-ribose	NULL
+	NULL
1	NULL
mM	NULL
aminoguanidine	NULL
108+10	NULL
98+16	NULL
113+20	NULL
60	NULL
mM	NULL
D-ribose	NULL
+	NULL
1	NULL
mM	NULL
aminoguanidine	NULL
67+18	NULL
88+9	NULL
139+52	NULL
40	NULL
mM	NULL
D-ribose	NULL
+	NULL
10	NULL
mM	NULL
NAC	NULL
104+*10	NULL
97+9	NULL
100+19	NULL
60	NULL
mM	NULL
D-ribose	NULL
+	NULL
10	NULL
mM	NULL
NAC	NULL
63+23	NULL
86+10	NULL
101+20	NULL
1	NULL
mM	NULL
aminoguanidine	NULL
100+15	NULL
110+11	NULL
96+16	NULL
10	NULL
mM	NULL
NAC	NULL
101+18	NULL
103+19	NULL
96+18	NULL
Values	NULL
are	NULL
presented	NULL
as	NULL
means+SD	NULL
of	NULL
at	NULL
least	NULL
four	NULL
individual	NULL
experiments	NULL
.	NULL

the	NULL
control	NULL
(	NULL
0	NULL
mM	NULL
D-ribose	NULL
)	NULL
when	NULL
the	NULL
cells	NULL
were	NULL
kept	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
40	NULL
and	NULL
60	NULL
mM	NULL
D-ribose	NULL
,	NULL
respectively	NULL
.	NULL

No	NULL
significant	NULL
changes	NULL
were	NULL
observed	NULL
with	NULL
the	NULL
B-actin	NULL
gene	NULL
promoter	NULL
(	NULL
112+12	NULL
and	NULL
87+14	NULL
%	NULL
for	NULL
40	NULL
and	NULL
60	NULL
mM	NULL
D-ribose	NULL
,	NULL
respectively	NULL
;	NULL
Fig	NULL
.	NULL

1	NULL
B	NULL
and	NULL
Table	NULL
I	NULL
)	NULL
.	NULL

In	NULL
terms	NULL
of	NULL
the	NULL
RSV-LTR	NULL
promoter	NULL
,	NULL
an	NULL
increase	NULL
was	NULL
observed	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
40	NULL
and	NULL
60	NULL
mM	NULL
D-ribose	NULL
(	NULL
252+60	NULL
and	NULL
258+95	NULL
%	NULL
,	NULL
respectively	NULL
;	NULL
Fig	NULL
.	NULL

1	NULL
C	NULL
and	NULL
Table	NULL
I	NULL
)	NULL
.	NULL

To	NULL
verify	NULL
that	NULL
the	NULL
suppression	NULL
of	NULL
the	NULL
insulin	NULL
gene	NULL
promoter	NULL
activity	NULL
by	NULL
D-ribose	NULL
is	NULL
relevant	NULL
to	NULL
the	NULL
induction	NULL
of	NULL
glycation	NULL
by	NULL
D-ribose	NULL
,	NULL
we	NULL
observed	NULL
the	NULL
effects	NULL
of	NULL
D-ribose	NULL
while	NULL
inhibiting	NULL
glycation	NULL
using	NULL
1	NULL
mM	NULL
aminoguanidine	NULL
.	NULL

The	NULL
results	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
A	NULL
revealed	NULL
that	NULL
addition	NULL
of	NULL
aminoguanidine	NULL
could	NULL
lead	NULL
Relative	NULL
Luciferase	NULL
Activity	NULL
L___L___	NULL
L_	NULL
b-Ribose	NULL
(	NULL
mM	NULL
)	NULL
-	NULL
0	NULL
-	NULL
40	NULL
60	NULL
0	NULL
a	NULL
40	NULL
60	NULL
0	NULL
o	NULL
40	NULL
_	NULL
60	NULL
0	NULL
1mM	NULL
noc	NULL
to-	NULL
+	NULL
+	NULL
#	NULL
08	NULL
4+	NULL
-on	NULL
#	NULL
0	NULL
-	NULL
+o	NULL
+	NULL
Aminoguanidine	NULL
Figure	NULL
2	NULL
.	NULL

Effects	NULL
of	NULL
aminoguanidine	NULL
on	NULL
D-ribose-induced	NULL
suppression	NULL
of	NULL
the	NULL
insulin	NULL
gene	NULL
promoter	NULL
.	NULL

A	NULL
reporter	NULL
gene	NULL
plasmid	NULL
containing	NULL
(	NULL
A	NULL
)	NULL
human	NULL
insulin	NULL
gene	NULL
promoter	NULL
(	NULL
30	NULL
)	NULL
,	NULL
(	NULL
B	NULL
)	NULL
human	NULL
B-actin	NULL
gene	NULL
promoter	NULL
(	NULL
29	NULL
)	NULL
,	NULL
or	NULL
(	NULL
C	NULL
)	NULL
RSV-LTR	NULL
(	NULL
28	NULL
)	NULL
was	NULL
transfected	NULL
into	NULL
HIT-T15	NULL
cells	NULL
.	NULL

6	NULL
h	NULL
after	NULL
the	NULL
transfection	NULL
,	NULL
1	NULL
mM	NULL
aminoguanidine	NULL
was	NULL
added	NULL
simultaneously	NULL
with	NULL
40	NULL
,	NULL
60	NULL
,	NULL
or	NULL
0	NULL
mM	NULL
(	NULL
vehicle	NULL
only	NULL
)	NULL
D-ribose	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
cultured	NULL
for	NULL
an	NULL
additional	NULL
72	NULL
h	NULL
,	NULL
followed	NULL
by	NULL
harvest	NULL
of	NULL
cell	NULL
lysates	NULL
,	NULL
which	NULL
were	NULL
then	NULL
subjected	NULL
to	NULL
luciferase	NULL
assays	NULL
.	NULL

Results	NULL
are	NULL
presented	NULL
as	NULL
relative	NULL
luciferase	NULL
activity	NULL
with	NULL
that	NULL
in	NULL
aminoguanidine-	NULL
or	NULL
D-ribose-untreated	NULL
(	NULL
vehicle	NULL
only	NULL
)	NULL
HIT-T15	NULL
cells	NULL
arbitrarily	NULL
set	NULL
at	NULL
100	NULL
%	NULL
.	NULL

All	NULL
data	NULL
are	NULL
presented	NULL
as	NULL
means+SD	NULL
of	NULL
at	NULL
least	NULL
four	NULL
individual	NULL
experiments	NULL
.	NULL

The	NULL
data	NULL
described	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
are	NULL
also	NULL
shown	NULL
by	NULL
shaded	NULL
bars	NULL
to	NULL
facilitate	NULL
comparison	NULL
.	NULL

146	NULL
_	NULL
Matsuoka	NULL
et	NULL
al	NULL
.	NULL

to	NULL
complete	NULL
or	NULL
partial	NULL
neutralization	NULL
of	NULL
the	NULL
promoter-suppress-ing	NULL
effects	NULL
(	NULL
48+19	NULL
to	NULL
108+10	NULL
%	NULL
for	NULL
40	NULL
mM	NULL
D-ribose	NULL
;	NULL
18+6	NULL
to	NULL
67+18	NULL
%	NULL
for	NULL
60	NULL
mM	NULL
D-ribose	NULL
;	NULL
Fig	NULL
.	NULL

2	NULL
A	NULL
and	NULL
Table	NULL
I	NULL
)	NULL
.	NULL

Regarding	NULL
the	NULL
RSV-LTR	NULL
promoter	NULL
activity	NULL
,	NULL
aminoguanidine	NULL
at	NULL
least	NULL
partially	NULL
blocked	NULL
the	NULL
D-ribose-responsive	NULL
increase	NULL
of	NULL
the	NULL
activity	NULL
(	NULL
252+60	NULL
to	NULL
113+20	NULL
%	NULL
for	NULL
40	NULL
mM	NULL
D-ribose	NULL
;	NULL
258+95	NULL
to	NULL
139+	NULL
52	NULL
%	NULL
for	NULL
60	NULL
mM	NULL
D-ribose	NULL
;	NULL
Fig	NULL
.	NULL

2	NULL
C	NULL
and	NULL
Table	NULL
I	NULL
)	NULL
.	NULL

In	NULL
the	NULL
absence	NULL
of	NULL
D-ribose	NULL
,	NULL
aminoguanidine	NULL
seemed	NULL
to	NULL
have	NULL
no	NULL
direct	NULL
effect	NULL
on	NULL
the	NULL
insulin	NULL
gene	NULL
promoter	NULL
as	NULL
well	NULL
as	NULL
B-actin	NULL
gene	NULL
and	NULL
RSV-LTR	NULL
promoter	NULL
activities	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
and	NULL
Table	NULL
I	NULL
)	NULL
.	NULL

These	NULL
neutralizing	NULL
effects	NULL
of	NULL
aminoguanidine	NULL
suggested	NULL
that	NULL
the	NULL
two	NULL
contras-tive	NULL
effects	NULL
of	NULL
D-ribose	NULL
,	NULL
its	NULL
suppressive	NULL
effects	NULL
on	NULL
the	NULL
insulin	NULL
gene	NULL
promoter	NULL
and	NULL
its	NULL
activating	NULL
effects	NULL
on	NULL
the	NULL
RSV-LTR	NULL
promoter	NULL
,	NULL
were	NULL
both	NULL
mediated	NULL
by	NULL
induction	NULL
of	NULL
glycation	NULL
.	NULL

Glycation	NULL
often	NULL
causes	NULL
an	NULL
increase	NULL
of	NULL
ROS	NULL
,	NULL
which	NULL
are	NULL
suggested	NULL
to	NULL
play	NULL
a	NULL
primary	NULL
role	NULL
in	NULL
glycation-induced	NULL
tissue	NULL
damage	NULL
(	NULL
18	NULL
,	NULL
33	NULL
)	NULL
.	NULL

Also	NULL
,	NULL
the	NULL
RSV-LTR	NULL
promoter	NULL
,	NULL
which	NULL
was	NULL
activated	NULL
by	NULL
D-ribose	NULL
in	NULL
a	NULL
glycation-dependent	NULL
manner	NULL
(	NULL
Figs	NULL
.	NULL

1	NULL
and	NULL
2	NULL
and	NULL
Table	NULL
I	NULL
)	NULL
,	NULL
is	NULL
known	NULL
to	NULL
be	NULL
a	NULL
target	NULL
of	NULL
ROS-induced	NULL
activation	NULL
through	NULL
the	NULL
cis-acting	NULL
motif	NULL
CArG	NULL
box	NULL
(	NULL
34	NULL
,	NULL
35	NULL
)	NULL
.	NULL

These	NULL
findings	NULL
tempted	NULL
us	NULL
to	NULL
consider	NULL
that	NULL
ROS	NULL
induction	NULL
may	NULL
also	NULL
be	NULL
involved	NULL
in	NULL
the	NULL
D-ribose-induced	NULL
,	NULL
glycation-dependent	NULL
changes	NULL
in	NULL
the	NULL
promoter	NULL
activities	NULL
.	NULL

Accordingly	NULL
,	NULL
we	NULL
inhibited	NULL
H	NULL
,	NULL
O	NULL
,	NULL
production	NULL
using	NULL
10	NULL
mM	NULL
NAC	NULL
and	NULL
examined	NULL
the	NULL
effects	NULL
on	NULL
the	NULL
changes	NULL
in	NULL
the	NULL
promoter	NULL
activities	NULL
.	NULL

Similar	NULL
to	NULL
the	NULL
results	NULL
obtained	NULL
with	NULL
aminoguanidine	NULL
,	NULL
addition	NULL
of	NULL
NAC	NULL
totally	NULL
or	NULL
partially	NULL
rescued	NULL
the	NULL
cells	NULL
from	NULL
glycation-dependent	NULL
reduction	NULL
of	NULL
the	NULL
insulin	NULL
gene	NULL
promoter	NULL
activity	NULL
(	NULL
48+19	NULL
to	NULL
104+10	NULL
%	NULL
for	NULL
40	NULL
mM	NULL
D-ribose	NULL
;	NULL
18+6	NULL
to	NULL
63+23	NULL
%	NULL
for	NULL
60	NULL
mM	NULL
D-ribose	NULL
;	NULL
Fig	NULL
.	NULL

3	NULL
A	NULL
and	NULL
Table	NULL
I	NULL
)	NULL
.	NULL

In	NULL
terms	NULL
of	NULL
the	NULL
RSV-LTR	NULL
promoter	NULL
,	NULL
the	NULL
D-ribose-induced	NULL
promoter	NULL
activation	NULL
was	NULL
totally	NULL
abolished	NULL
(	NULL
252+60	NULL
to	NULL
100+19	NULL
%	NULL
for	NULL
40	NULL
mM	NULL
D-ribose	NULL
;	NULL
to	NULL
101+*20	NULL
%	NULL
for	NULL
60	NULL
mM	NULL
D-ribose	NULL
;	NULL
Fig	NULL
.	NULL

3	NULL
C	NULL
and	NULL
Table	NULL
I	NULL
)	NULL
.	NULL

These	NULL
results	NULL
indicated	NULL
that	NULL
ROS	NULL
induction	NULL
mediates	NULL
the	NULL
glycation-dependent	NULL
suppression	NULL
of	NULL
the	NULL
insulin	NULL
gene	NULL
promoter	NULL
as	NULL
well	NULL
as	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
RSV-LTR	NULL
promoter	NULL
.	NULL

(	NULL
%	NULL
)	NULL
Relative	NULL
Luciferase	NULL
Activity	NULL
L____L___J	NULL
D-Ribose	NULL
(	NULL
mM	NULL
)	NULL
40	NULL
60	NULL
0	NULL
10mM	NULL
-o-	NULL
4	NULL
-	NULL
++	NULL
son	NULL
to-	NULL
+	NULL
+	NULL
son	NULL
do-	NULL
404	NULL
N-Acetylcysteine	NULL
Figure	NULL
3	NULL
.	NULL

Effects	NULL
of	NULL
NAC	NULL
on	NULL
D-ribose-induced	NULL
suppression	NULL
of	NULL
the	NULL
insulin	NULL
gene	NULL
promoter	NULL
.	NULL

A	NULL
reporter	NULL
gene	NULL
plasmid	NULL
containing	NULL
(	NULL
A	NULL
)	NULL
human	NULL
insulin	NULL
gene	NULL
promoter	NULL
(	NULL
30	NULL
)	NULL
,	NULL
(	NULL
B	NULL
)	NULL
human	NULL
B-actin	NULL
gene	NULL
promoter	NULL
(	NULL
29	NULL
)	NULL
,	NULL
or	NULL
(	NULL
C	NULL
)	NULL
RSV-LTR	NULL
promoter	NULL
(	NULL
28	NULL
)	NULL
was	NULL
transfected	NULL
into	NULL
HIT-T15	NULL
cells	NULL
.	NULL

6	NULL
h	NULL
after	NULL
transfection	NULL
,	NULL
10	NULL
mM	NULL
NAC	NULL
was	NULL
added	NULL
simultaneously	NULL
with	NULL
40	NULL
,	NULL
60	NULL
,	NULL
or	NULL
0	NULL
mM	NULL
(	NULL
vehicle	NULL
only	NULL
)	NULL
D-ribose	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
cultured	NULL
for	NULL
an	NULL
additional	NULL
72	NULL
h	NULL
,	NULL
followed	NULL
by	NULL
harvest	NULL
of	NULL
cell	NULL
lysates	NULL
,	NULL
which	NULL
were	NULL
then	NULL
subjected	NULL
to	NULL
luciferase	NULL
assays	NULL
.	NULL

Results	NULL
are	NULL
presented	NULL
as	NULL
relative	NULL
luciferase	NULL
activity	NULL
with	NULL
that	NULL
in	NULL
NAC-	NULL
or	NULL
D-ribose-untreated	NULL
(	NULL
vehicle	NULL
only	NULL
)	NULL
HIT-T15	NULL
cells	NULL
arbitrarily	NULL
set	NULL
at	NULL
100	NULL
%	NULL
.	NULL

All	NULL
data	NULL
are	NULL
presented	NULL
as	NULL
means+SD	NULL
of	NULL
at	NULL
least	NULL
four	NULL
individual	NULL
experiments	NULL
.	NULL

The	NULL
data	NULL
described	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
are	NULL
also	NULL
shown	NULL
by	NULL
shaded	NULL
bars	NULL
to	NULL
facilitate	NULL
comparison	NULL
.	NULL

A	NULL
B	NULL
D-Ribose	NULL
(	NULL
mM	NULL
)	NULL
0	NULL
40	NULL
60	NULL
0	NULL
40	NULL
40	NULL
40	NULL
0	NULL
_	NULL
0	NULL
10	NULL
mM	NULL
N-acetylcysteine	NULL
~	NULL
=	NULL
*	NULL
=	NULL
=	NULL
4	NULL
=	NULL
+4	NULL
&	NULL
1	NULL
mM	NULL
Aminoguanidine	NULL
_	NULL
=	NULL
=	NULL
=	NULL
=	NULL
=	NULL
=	NULL
+	NULL
=	NULL
+4	NULL
one-	NULL
C	NULL
M	NULL
H	NULL
-	NULL
a	NULL
0	NULL
a	NULL
#	NULL
ms	NULL
=~	NULL
185	NULL
1°	NULL
2	NULL
3	NULL
4	NULL
§	NULL
60	NULL
7	NULL
8	NULL
9	NULL
Figure	NULL
4	NULL
.	NULL

Effects	NULL
of	NULL
D-ribose	NULL
on	NULL
the	NULL
amounts	NULL
of	NULL
insulin	NULL
gene	NULL
tran-scripts	NULL
.	NULL

Northern	NULL
blot	NULL
analyses	NULL
were	NULL
performed	NULL
using	NULL
a	NULL
mouse	NULL
insulin	NULL
II	NULL
cDNA	NULL
(	NULL
31	NULL
)	NULL
.	NULL

Each	NULL
lane	NULL
contained	NULL
10	NULL
pg	NULL
total	NULL
RNA	NULL
isolated	NULL
from	NULL
HIT-T15	NULL
cells	NULL
grown	NULL
for	NULL
5	NULL
d	NULL
under	NULL
various	NULL
conditions	NULL
.	NULL

Blot	NULL
A	NULL
,	NULL
cells	NULL
were	NULL
kept	NULL
in	NULL
medium	NULL
containing	NULL
0	NULL
mM	NULL
(	NULL
vehicle	NULL
only	NULL
)	NULL
,	NULL
40	NULL
mM	NULL
,	NULL
or	NULL
60	NULL
mM	NULL
D-ribose	NULL
(	NULL
lanes	NULL
7-3	NULL
)	NULL
.	NULL

Blot	NULL
B	NULL
,	NULL
the	NULL
culture	NULL
medium	NULL
contained	NULL
0	NULL
mM	NULL
(	NULL
vehicle	NULL
only	NULL
;	NULL
lanes	NULL
4	NULL
,	NULL
8	NULL
,	NULL
and	NULL
9	NULL
)	NULL
or	NULL
40	NULL
mM	NULL
(	NULL
lanes	NULL
5-7	NULL
)	NULL
D-ribose	NULL
along	NULL
with	NULL
10	NULL
mM	NULL
NAC	NULL
(	NULL
lanes	NULL
6	NULL
and	NULL
8	NULL
)	NULL
or	NULL
1	NULL
mM	NULL
aminoguanidine	NULL
(	NULL
lanes	NULL
7	NULL
and	NULL
9	NULL
)	NULL
.	NULL

In	NULL
lanes	NULL
where	NULL
aminoguanidine	NULL
or	NULL
NAC	NULL
was	NULL
not	NULL
added	NULL
,	NULL
their	NULL
vehicles	NULL
were	NULL
added	NULL
instead	NULL
.	NULL

The	NULL
exposure	NULL
time	NULL
was	NULL
24	NULL
h	NULL
for	NULL
both	NULL
blots	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
in	NULL
two	NULL
independent	NULL
experiments	NULL
.	NULL

Glycation-dependent	NULL
reduction	NULL
of	NULL
insulin	NULL
mRNA	NULL
amount	NULL
and	NULL
insulin	NULL
content	NULL
.	NULL

To	NULL
examine	NULL
whether	NULL
the	NULL
glycation-dependent	NULL
suppression	NULL
of	NULL
the	NULL
insulin	NULL
gene	NULL
promoter	NULL
caused	NULL
the	NULL
reduction	NULL
of	NULL
its	NULL
transcripts	NULL
,	NULL
insulin	NULL
mRNA	NULL
levels	NULL
were	NULL
measured	NULL
by	NULL
Northern	NULL
blot	NULL
analyses	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

Amounts	NULL
of	NULL
insulin	NULL
mRNA	NULL
,	NULL
detected	NULL
as	NULL
0.5-kb	NULL
bands	NULL
on	NULL
the	NULL
blots	NULL
,	NULL
decreased	NULL
when	NULL
the	NULL
HIT-T15	NULL
cells	NULL
were	NULL
kept	NULL
for	NULL
5	NULL
d	NULL
with	NULL
40	NULL
mM	NULL
D-ribose	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

Further	NULL
decrease	NULL
was	NULL
observed	NULL
when	NULL
they	NULL
were	NULL
kept	NULL
with	NULL
60	NULL
mM	NULL
D-ribose	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

Also	NULL
in	NULL
agreement	NULL
with	NULL
the	NULL
observations	NULL
on	NULL
promoter	NULL
activities	NULL
,	NULL
1	NULL
mM	NULL
aminoguanidine	NULL
and	NULL
10	NULL
mM	NULL
NAC	NULL
neutralized	NULL
the	NULL
suppressive	NULL
effects	NULL
of	NULL
D-ribose	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
lanes	NULL
4-9	NULL
)	NULL
.	NULL

We	NULL
also	NULL
checked	NULL
for	NULL
possible	NULL
changes	NULL
in	NULL
insulin	NULL
content	NULL
.	NULL

In	NULL
agreement	NULL
with	NULL
the	NULL
decrease	NULL
in	NULL
insulin	NULL
mRNA	NULL
,	NULL
the	NULL
insulin	NULL
content	NULL
of	NULL
cells	NULL
cultured	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
40	NULL
mM	NULL
D-ribose	NULL
for	NULL
5	NULL
d	NULL
was	NULL
41+6	NULL
pmol/mg	NULL
protein	NULL
(	NULL
average+SD	NULL
;	NULL
n	NULL
=	NULL
5	NULL
)	NULL
,	NULL
which	NULL
was	NULL
only	NULL
18	NULL
%	NULL
of	NULL
that	NULL
of	NULL
the	NULL
control	NULL
cells	NULL
kept	NULL
for	NULL
the	NULL
same	NULL
period	NULL
without	NULL
D-ribose	NULL
(	NULL
229+52	NULL
pmol/mg	NULL
protein	NULL
;	NULL
n	NULL
=	NULL
5	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
glycation-dependent	NULL
suppression	NULL
of	NULL
the	NULL
insulin	NULL
gene	NULL
promoter	NULL
seemed	NULL
to	NULL
have	NULL
reduced	NULL
the	NULL
amount	NULL
of	NULL
its	NULL
transcript	NULL
and	NULL
protein	NULL
in	NULL
the	NULL
cells	NULL
.	NULL

Glycation-dependent	NULL
reduction	NULL
of	NULL
DNA-binding	NULL
activity	NULL
of	NULL
PDX-1	NULL
.	NULL

To	NULL
obtain	NULL
clues	NULL
to	NULL
understanding	NULL
the	NULL
molecular	NULL
basis	NULL
of	NULL
the	NULL
suppression	NULL
of	NULL
insulin	NULL
gene	NULL
promoter	NULL
activity	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
possible	NULL
glycation-induced	NULL
changes	NULL
in	NULL
the	NULL
activity	NULL
of	NULL
a	NULL
transcription	NULL
factor	NULL
of	NULL
the	NULL
insulin	NULL
gene	NULL
,	NULL
PDX-1/IPF1/STF-1	NULL
.	NULL

Using	NULL
the	NULL
human	NULL
A3	NULL
region	NULL
as	NULL
a	NULL
binding	NULL
probe	NULL
,	NULL
gel	NULL
mobility	NULL
shift	NULL
analyses	NULL
were	NULL
performed	NULL
.	NULL

Before	NULL
evaluating	NULL
the	NULL
effects	NULL
of	NULL
glycation	NULL
,	NULL
the	NULL
specificity	NULL
of	NULL
the	NULL
binding	NULL
to	NULL
the	NULL
probe	NULL
was	NULL
verified	NULL
using	NULL
an	NULL
anti-PDX-1	NULL
(	NULL
IPF1	NULL
)	NULL
antiserum	NULL
(	NULL
30	NULL
)	NULL
,	NULL
wild	NULL
and	NULL
mutated	NULL
competitors	NULL
,	NULL
and	NULL
the	NULL
hUPE3	NULL
competitor	NULL
reproducing	NULL
the	NULL
hUPE3	NULL
site	NULL
of	NULL
the	NULL
human	NULL
glucokinase	NULL
gene	NULL
promoter	NULL
,	NULL
which	NULL
we	NULL
recently	NULL
showed	NULL
can	NULL
bind	NULL
PDX-1	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
C	NULL
and	NULL
reference	NULL
30	NULL
)	NULL
.	NULL

The	NULL
supershift	NULL
of	NULL
the	NULL
band	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
as	NULL
well	NULL
as	NULL
specific	NULL
competition	NULL
by	NULL
the	NULL
competitors	NULL
(	NULL
lanes	NULL
4-6	NULL
)	NULL
,	NULL
demonstrated	NULL
that	NULL
PDX-1	NULL
in	NULL
HIT	NULL
cells	NULL
specifically	NULL
binds	NULL
to	NULL
the	NULL
human	NULL
A3	NULL
probe	NULL
.	NULL

The	NULL
effects	NULL
of	NULL
glycation	NULL
on	NULL
the	NULL
DNA-binding	NULL
activity	NULL
of	NULL
PDX-1	NULL
were	NULL
evaluated	NULL
in	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
A	NULL
and	NULL
B	NULL
.	NULL

When	NULL
cells	NULL
were	NULL
kept	NULL
for	NULL
5	NULL
d	NULL
with	NULL
40	NULL
or	NULL
60	NULL
mM	NULL
D-ribose	NULL
,	NULL
marked	NULL
reduction	NULL
of	NULL
PDX-1	NULL
binding	NULL
to	NULL
the	NULL
A3	NULL
probe	NULL
was	NULL
observed	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
A	NULL
)	NULL
.	NULL

How-ever	NULL
,	NULL
coexistence	NULL
of	NULL
1	NULL
mM	NULL
aminoguanidine	NULL
or	NULL
10	NULL
mM	NULL
NAC	NULL
in	NULL
the	NULL
media	NULL
prevented	NULL
the	NULL
effects	NULL
of	NULL
D-ribose	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
B	NULL
,	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
.	NULL

In	NULL
the	NULL
absence	NULL
of	NULL
D-ribose	NULL
,	NULL
aminoguanidine	NULL
or	NULL
NAC	NULL
alone	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
the	NULL
PDX-1	NULL
activity	NULL
.	NULL

These	NULL
results	NULL
indicated	NULL
that	NULL
D-ribose	NULL
suppressed	NULL
the	NULL
DNA-binding	NULL
activity	NULL
of	NULL
PDX-1	NULL
in	NULL
a	NULL
manner	NULL
dependent	NULL
on	NULL
glycation	NULL
and	NULL
ROS	NULL
.	NULL

Reversibility	NULL
of	NULL
the	NULL
effects	NULL
of	NULL
D-ribose	NULL
.	NULL

To	NULL
investigate	NULL
whether	NULL
the	NULL
D-ribose	NULL
effects	NULL
on	NULL
the	NULL
insulin	NULL
gene	NULL
transcription	NULL
in	NULL
HIT-T15	NULL
cells	NULL
are	NULL
reversible	NULL
or	NULL
not	NULL
,	NULL
we	NULL
kept	NULL
the	NULL
cells	NULL
under	NULL
40	NULL
mM	NULL
D-ribose	NULL
for	NULL
5	NULL
d	NULL
and	NULL
then	NULL
started	NULL
culturing	NULL
the	NULL
cells	NULL
in	NULL
media	NULL
containing	NULL
no	NULL
D-ribose	NULL
.	NULL

Total	NULL
RNA	NULL
and	NULL
nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
those	NULL
cells	NULL
at	NULL
2	NULL
d	NULL
and	NULL
5	NULL
d	NULL
after	NULL
D-ribose	NULL
was	NULL
eliminated	NULL
,	NULL
and	NULL
Northern	NULL
blot	NULL
analyses	NULL
and	NULL
gel	NULL
mobility	NULL
shift	NULL
analyses	NULL
were	NULL
performed	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

6	NULL
,	NULL
there	NULL
was	NULL
only	NULL
slight	NULL
recovery	NULL
from	NULL
the	NULL
decrease	NULL
in	NULL
the	NULL
insulin	NULL
mRNA	NULL
amounts	NULL
caused	NULL
by	NULL
40	NULL
mM	NULL
D-ribose	NULL
,	NULL
even	NULL
after	NULL
the	NULL
cells	NULL
were	NULL
kept	NULL
in	NULL
D-ribose-free	NULL
medium	NULL
for	NULL
5	NULL
d.	NULL
Similarly	NULL
,	NULL
5-d	NULL
culture	NULL
in	NULL
D-ribose-free	NULL
medium	NULL
did	NULL
not	NULL
lead	NULL
to	NULL
recovery	NULL
of	NULL
the	NULL
normal	NULL
DNA-binding	NULL
activity	NULL
for	NULL
PDX-1	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

These	NULL
observations	NULL
suggest	NULL
that	NULL
the	NULL
changes	NULL
that	NULL
occurred	NULL
in	NULL
the	NULL
HIT-T15	NULL
cells	NULL
because	NULL
of	NULL
the	NULL
D-ribose-induced	NULL
glycation	NULL
and	NULL
ROS	NULL
are	NULL
almost	NULL
,	NULL
if	NULL
not	NULL
totally	NULL
,	NULL
irreversible	NULL
.	NULL

Discussion	NULL
Under	NULL
hyperglycemia	NULL
,	NULL
the	NULL
production	NULL
of	NULL
various	NULL
reducing	NULL
sugars	NULL
such	NULL
as	NULL
glucose	NULL
,	NULL
glucose-6-phosphate	NULL
,	NULL
and	NULL
fructose	NULL
increases	NULL
through	NULL
glycolysis	NULL
and	NULL
the	NULL
polyol	NULL
pathway	NULL
.	NULL

All	NULL
of	NULL
these	NULL
reducing	NULL
sugars	NULL
are	NULL
known	NULL
to	NULL
promote	NULL
glycation	NULL
reactions	NULL
of	NULL
various	NULL
proteins	NULL
(	NULL
19	NULL
,	NULL
36	NULL
)	NULL
.	NULL

In	NULL
line	NULL
with	NULL
these	NULL
facts	NULL
,	NULL
an	NULL
increase	NULL
in	NULL
AGE	NULL
was	NULL
detected	NULL
in	NULL
various	NULL
tissues	NULL
of	NULL
streptozotocin-induced	NULL
diabetic	NULL
rats	NULL
(	NULL
16	NULL
)	NULL
.	NULL

The	NULL
pancreatic	NULL
B	NULL
cells	NULL
,	NULL
which	NULL
express	NULL
the	NULL
high	NULL
K	NULL
,	NULL
,	NULL
glucose	NULL
transporter	NULL
GLUT2	NULL
abundantly	NULL
and	NULL
thereby	NULL
display	NULL
highly	NULL
efficient	NULL
glucose	NULL
uptake	NULL
when	NULL
exposed	NULL
to	NULL
high	NULL
glucose	NULL
concentration	NULL
,	NULL
were	NULL
recently	NULL
shown	NULL
to	NULL
contain	NULL
AGE	NULL
(	NULL
37	NULL
)	NULL
,	NULL
providing	NULL
support	NULL
for	NULL
the	NULL
idea	NULL
that	NULL
glycation	NULL
reaction	NULL
may	NULL
underlie	NULL
the	NULL
glucose	NULL
toxicity	NULL
to	NULL
B	NULL
cells	NULL
.	NULL

In	NULL
the	NULL
present	NULL
study	NULL
,	NULL
we	NULL
established	NULL
an	NULL
in	NULL
vitro	NULL
model	NULL
cell	NULL
system	NULL
that	NULL
allows	NULL
us	NULL
to	NULL
evaluate	NULL
the	NULL
potential	NULL
effects	NULL
of	NULL
glycation	NULL
and	NULL
the	NULL
consequent	NULL
increase	NULL
of	NULL
ROS	NULL
on	NULL
the	NULL
B	NULL
cell	NULL
function	NULL
.	NULL

Among	NULL
reducing	NULL
sugars	NULL
that	NULL
potentially	NULL
induce	NULL
glycation	NULL
,	NULL
D-ribose	NULL
is	NULL
outstanding	NULL
for	NULL
its	NULL
very	NULL
potent	NULL
activity	NULL
and	NULL
thus	NULL
is	NULL
often	NULL
used	NULL
in	NULL
in	NULL
vitro	NULL
studies	NULL
as	NULL
an	NULL
inducer	NULL
of	NULL
glycation	NULL
(	NULL
19	NULL
,	NULL
20	NULL
)	NULL
.	NULL

The	NULL
use	NULL
of	NULL
D-ribose	NULL
in	NULL
this	NULL
study	NULL
could	NULL
induce	NULL
glycation	NULL
in	NULL
HIT-T15	NULL
cells	NULL
during	NULL
a	NULL
relatively	NULL
short	NULL
period	NULL
(	NULL
<	NULL
72	NULL
h	NULL
)	NULL
between	NULL
the	NULL
transfection	NULL
of	NULL
the	NULL
reporter	NULL
gene	NULL
plasmids	NULL
and	NULL
harvest	NULL
of	NULL
the	NULL
cellular	NULL
extracts	NULL
.	NULL

This	NULL
made	NULL
it	NULL
possible	NULL
to	NULL
show	NULL
that	NULL
glycation	NULL
,	NULL
at	NULL
least	NULL
when	NULL
induced	NULL
in	NULL
HIT-T15	NULL
cells	NULL
,	NULL
suppresses	NULL
the	NULL
insulin	NULL
gene	NULL
promoter	NULL
(	NULL
Figs	NULL
.	NULL

1	NULL
and	NULL
2	NULL
)	NULL
.	NULL

In	NULL
agreement	NULL
with	NULL
this	NULL
decrease	NULL
in	NULL
the	NULL
promoter	NULL
activity	NULL
,	NULL
we	NULL
observed	NULL
decreases	NULL
in	NULL
the	NULL
insulin	NULL
mRNA	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
and	NULL
insulin	NULL
content	NULL
,	NULL
supporting	NULL
the	NULL
idea	NULL
that	NULL
glycation	NULL
and	NULL
ROS-dependent	NULL
suppression	NULL
of	NULL
the	NULL
insulin	NULL
gene	NULL
promoter	NULL
caused	NULL
impairment	NULL
of	NULL
insulin	NULL
synthesis	NULL
in	NULL
HIT-T15	NULL
cells	NULL
.	NULL

Glycation	NULL
Suppresses	NULL
Insulin	NULL
Gene	NULL
Promoter	NULL
Activity	NULL
147	NULL
A	NULL
D-Ribose	NULL
(	NULL
mM	NULL
)	NULL
0	NULL
40	NULL
_	NULL
60	NULL
probe	NULL
Competitor	NULL
(	NULL
x100	NULL
)	NULL
*	NULL
'	NULL
=	NULL
=	NULL
~	NULL
o=	NULL
+	NULL
B	NULL
p-Ribose	NULL
(	NULL
mM	NULL
)	NULL
0	NULL
40	NULL
40	NULL
40	NULL
0	NULL
0	NULL
0	NULL
10	NULL
mM	NULL
N-acetylcysteine	NULL
_	NULL
=	NULL
=	NULL
+	NULL
=	NULL
+	NULL
=	NULL
=	NULL
1	NULL
mM	NULL
Aminoguanidine	NULL
=	NULL
=	NULL
=	NULL
+	NULL
=	NULL
f	NULL
=	NULL
Competitor	NULL
(	NULL
x100	NULL
)	NULL
=	NULL
-	NULL
=	NULL
=	NULL
=	NULL
-	NULL
%	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
C	NULL
Anti-PDX-1	NULL
antiserum	NULL
_-	NULL
+	NULL
=	NULL
n	NULL
=	NULL
=-Pre-immune	NULL
serum	NULL
s	NULL
is	NULL
+	NULL
s	NULL
w	NULL
o	NULL
competitor	NULL
(	NULL
X100	NULL
)	NULL
=	NULL
-	NULL
-	NULL
W	NULL
M	NULL
U	NULL
wfe	NULL
Figure	NULL
5	NULL
.	NULL

Effects	NULL
of	NULL
D-ribose	NULL
on	NULL
the	NULL
DNA-binding	NULL
activity	NULL
of	NULL
PDX-1	NULL
.	NULL

Gel-mobility	NULL
shift	NULL
analyses	NULL
were	NULL
performed	NULL
to	NULL
evaluate	NULL
possible	NULL
effects	NULL
of	NULL
-ribose	NULL
on	NULL
the	NULL
DNA-binding	NULL
activity	NULL
of	NULL
PDX-1	NULL
.	NULL

A	NULL
double-stranded	NULL
oligonucleotide	NULL
reproducing	NULL
the	NULL
human	NULL
insulin	NULL
gene	NULL
A3	NULL
.	NULL

”	NULL
.	NULL

.	NULL

¥	NULL
#	NULL
region	NULL
and	NULL
surrounding	NULL
sequences	NULL
(	NULL
-201	NULL
to	NULL
-224	NULL
;	NULL
5-GTTAAGAC-®	NULL
TCTAATGACCCGCTGG-3	NULL
'	NULL
)	NULL
was	NULL
used	NULL
as	NULL
a	NULL
binding	NULL
probe	NULL
.	NULL

(	NULL
4	NULL
)	NULL
f	NULL
Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
HIT-T15	NULL
cells	NULL
kept	NULL
for	NULL
5	NULL
d	NULL
in	NULL
medium	NULL
containing	NULL
0	NULL
mM	NULL
(	NULL
vehicle	NULL
only	NULL
)	NULL
,	NULL
40	NULL
mM	NULL
,	NULL
or	NULL
60	NULL
mM	NULL
D-ribose	NULL
3	NULL
(	NULL
lanes	NULL
2-4	NULL
)	NULL
.	NULL

Lane	NULL
5	NULL
was	NULL
the	NULL
same	NULL
as	NULL
lane	NULL
2	NULL
,	NULL
except	NULL
that	NULL
100-fold	NULL
excess	NULL
Rc	NULL
of	NULL
unlabeled	NULL
competitor	NULL
was	NULL
added	NULL
.	NULL

Lane	NULL
7	NULL
included	NULL
no	NULL
nuclear	NULL
ex-	NULL
#	NULL
>	NULL
@	NULL
®	NULL
tract	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Nuclear	NULL
extracts	NULL
prepared	NULL
from	NULL
cells	NULL
kept	NULL
for	NULL
5	NULL
d	NULL
in	NULL
0	NULL
mM	NULL
(	NULL
vehicle	NULL
only	NULL
)	NULL
or	NULL
40	NULL
mM	NULL
D-ribose	NULL
with	NULL
or	NULL
without	NULL
the	NULL
coexistence	NULL
of	NULL
1	NULL
mM	NULL
NAC	NULL
(	NULL
lanes	NULL
4	NULL
and	NULL
6	NULL
)	NULL
or	NULL
10	NULL
mM	NULL
aminoguanidine	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
5	NULL
)	NULL
were	NULL
used	NULL
.	NULL

In	NULL
lane	NULL
7	NULL
,	NULL
100-fold	NULL
excess	NULL
of	NULL
unlabeled	NULL
competitor	NULL
was	NULL
added	NULL
.	NULL

(	NULL
C	NULL
)	NULL
The	NULL
specificity	NULL
and	NULL
identity	NULL
of	NULL
the	NULL
DNA-binding	NULL
complex	NULL
were	NULL
analyzed	NULL
.	NULL

Anti-PDX-1	NULL
(	NULL
IPF1	NULL
)	NULL
antiserum	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
or	NULL
preimmune	NULL
serum	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
was	NULL
added	NULL
to	NULL
the	NULL
binding	NULL
reaction	NULL
before	NULL
addition	NULL
of	NULL
the	NULL
probe	NULL
.	NULL

The	NULL
binding	NULL
specificity	NULL
was	NULL
evaluated	NULL
using	NULL
the	NULL
unlabeled	NULL
wild-type	NULL
(	NULL
W	NULL
,	NULL
lane	NULL
4	NULL
)	NULL
,	NULL
mutated-type	NULL
(	NULL
M	NULL
,	NULL
TACCCGCTGG-3	NULL
'	NULL
,	NULL
lane	NULL
5	NULL
)	NULL
,	NULL
and	NULL
hUPE3	NULL
(	NULL
U	NULL
[	NULL
reference	NULL
30	NULL
]	NULL
,	NULL
lane	NULL
6	NULL
)	NULL
competitor	NULL
.	NULL

The	NULL
arrow	NULL
indicates	NULL
the	NULL
supershifted	NULL
band	NULL
.	NULL

Similar	NULL
results	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
were	NULL
obtained	NULL
in	NULL
at	NULL
least	NULL
two	NULL
independent	NULL
experiments	NULL
.	NULL

148	NULL
_-	NULL
Matsuoka	NULL
et	NULL
al	NULL
.	NULL

p-Ribose	NULL
0	NULL
40	NULL
40	NULL
40	NULL
L	NULL
o	NULL
bo	NULL
d	NULL
(	NULL
2	NULL
d	NULL
)	NULL
(	NULL
5	NULL
d	NULL
)	NULL
one-	NULL
-	NULL
#	NULL
#	NULL
28S	NULL
--	NULL
185	NULL
===	NULL
3	NULL
4	NULL
1	NULL
2	NULL
Figure	NULL
6	NULL
.	NULL

Evaluation	NULL
of	NULL
reversibility	NULL
of	NULL
the	NULL
reduced	NULL
insulin	NULL
mRNA	NULL
caused	NULL
by	NULL
D-ribose	NULL
.	NULL

Northern	NULL
blot	NULL
analyses	NULL
were	NULL
performed	NULL
using	NULL
mouse	NULL
insulin	NULL
II	NULL
eDNA	NULL
(	NULL
31	NULL
)	NULL
as	NULL
a	NULL
probe	NULL
.	NULL

Each	NULL
lane	NULL
contained	NULL
10	NULL
pg	NULL
total	NULL
RNA	NULL
isolated	NULL
from	NULL
HIT-T15	NULL
cells	NULL
grown	NULL
for	NULL
5	NULL
,	NULL
7	NULL
,	NULL
and	NULL
10	NULL
d	NULL
under	NULL
various	NULL
conditions	NULL
;	NULL
the	NULL
cells	NULL
were	NULL
kept	NULL
in	NULL
medium	NULL
containing	NULL
0	NULL
mM	NULL
(	NULL
vehicle	NULL
only	NULL
,	NULL
lane	NULL
7	NULL
)	NULL
or	NULL
40	NULL
mM	NULL
D-ribose	NULL
for	NULL
5	NULL
d	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
or	NULL
were	NULL
kept	NULL
for	NULL
5	NULL
d	NULL
in	NULL
40	NULL
mM	NULL
D-ribose	NULL
and	NULL
then	NULL
under	NULL
D-ribose-free	NULL
conditions	NULL
for	NULL
2	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
or	NULL
5	NULL
d	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

The	NULL
exposure	NULL
time	NULL
was	NULL
24	NULL
h.	NULL
Similar	NULL
results	NULL
were	NULL
obtained	NULL
in	NULL
two	NULL
independent	NULL
experiments	NULL
.	NULL

Use	NULL
of	NULL
NAC	NULL
allowed	NULL
us	NULL
to	NULL
show	NULL
the	NULL
involvement	NULL
of	NULL
ROS	NULL
in	NULL
glycation-dependent	NULL
suppression	NULL
of	NULL
the	NULL
insulin	NULL
gene	NULL
promoter	NULL
.	NULL

Lines	NULL
of	NULL
evidence	NULL
have	NULL
suggested	NULL
to	NULL
date	NULL
that	NULL
ROS	NULL
,	NULL
which	NULL
are	NULL
known	NULL
to	NULL
be	NULL
induced	NULL
in	NULL
vivo	NULL
when	NULL
reducing	NULL
sugars	NULL
or	NULL
unsaturated	NULL
lipids	NULL
are	NULL
increased	NULL
,	NULL
may	NULL
cause	NULL
oxidative	NULL
stress	NULL
and	NULL
damage	NULL
to	NULL
proteins	NULL
in	NULL
diabetes	NULL
(	NULL
18	NULL
,	NULL
33	NULL
)	NULL
.	NULL

Although	NULL
the	NULL
ROS	NULL
that	NULL
caused	NULL
suppression	NULL
of	NULL
the	NULL
insulin	NULL
gene	NULL
promoter	NULL
in	NULL
our	NULL
present	NULL
study	NULL
were	NULL
artificially	NULL
induced	NULL
by	NULL
D-ribose	NULL
,	NULL
ROS	NULL
can	NULL
be	NULL
physi-ologically	NULL
generated	NULL
by	NULL
reducing	NULL
sugars	NULL
or	NULL
unsaturated	NULL
lipids	NULL
in	NULL
vivo	NULL
,	NULL
and	NULL
may	NULL
cause	NULL
similar	NULL
phenomena	NULL
in	NULL
diabetes	NULL
.	NULL

We	NULL
should	NULL
note	NULL
that	NULL
,	NULL
as	NULL
could	NULL
be	NULL
expected	NULL
from	NULL
the	NULL
strong	NULL
deoxidizing	NULL
activity	NULL
,	NULL
D-ribose	NULL
caused	NULL
reduction	NULL
in	NULL
cell	NULL
viability	NULL
.	NULL

In	NULL
proportion	NULL
to	NULL
the	NULL
D-ribose	NULL
concentration	NULL
,	NULL
the	NULL
speed	NULL
of	NULL
cell	NULL
growth	NULL
decreases	NULL
;	NULL
when	NULL
cells	NULL
were	NULL
cultured	NULL
for	NULL
72	NULL
h	NULL
in	NULL
40	NULL
and	NULL
60	NULL
mM	NULL
D-ribose	NULL
,	NULL
cell	NULL
numbers	NULL
increased	NULL
2.6-	NULL
and	NULL
1.3-fold	NULL
,	NULL
re-spectively	NULL
,	NULL
which	NULL
were	NULL
smaller	NULL
than	NULL
the	NULL
3.3-fold	NULL
increase	NULL
observed	NULL
when	NULL
they	NULL
were	NULL
kept	NULL
without	NULL
D-ribose	NULL
.	NULL

Microscopically	NULL
,	NULL
after	NULL
the	NULL
72-h	NULL
culture	NULL
with	NULL
D-ribose	NULL
,	NULL
there	NULL
were	NULL
some	NULL
cells	NULL
whose	NULL
attachment	NULL
to	NULL
the	NULL
plate	NULL
appeared	NULL
to	NULL
be	NULL
loose	NULL
.	NULL

These	NULL
effects	NULL
of	NULL
D-ribose	NULL
were	NULL
almost	NULL
totally	NULL
prevented	NULL
by	NULL
addition	NULL
of	NULL
1	NULL
mM	NULL
aminoguanidine	NULL
or	NULL
10	NULL
mM	NULL
NAC	NULL
(	NULL
Matsuoka	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Y.	NULL
Kajimoto	NULL
,	NULL
unpublished	NULL
observations	NULL
)	NULL
.	NULL

Although	NULL
the	NULL
pathophysiological	NULL
significance	NULL
of	NULL
these	NULL
phenomena	NULL
is	NULL
not	NULL
known	NULL
,	NULL
such	NULL
inhibitory	NULL
effects	NULL
of	NULL
glycation	NULL
or	NULL
ROS	NULL
on	NULL
cell	NULL
growth	NULL
or	NULL
survival	NULL
may	NULL
explain	NULL
in	NULL
part	NULL
the	NULL
B	NULL
cell	NULL
glucose	NULL
toxicity	NULL
.	NULL

How-ever	NULL
,	NULL
we	NULL
assume	NULL
that	NULL
the	NULL
suppressive	NULL
effect	NULL
on	NULL
the	NULL
promoter	NULL
activity	NULL
,	NULL
which	NULL
was	NULL
observed	NULL
for	NULL
the	NULL
insulin	NULL
gene	NULL
but	NULL
not	NULL
for	NULL
the	NULL
B-actin	NULL
gene	NULL
,	NULL
should	NULL
be	NULL
taken	NULL
as	NULL
an	NULL
event	NULL
that	NULL
is	NULL
distinguishable	NULL
from	NULL
the	NULL
effects	NULL
on	NULL
cell	NULL
viability	NULL
.	NULL

The	NULL
clear	NULL
difference	NULL
in	NULL
the	NULL
responses	NULL
to	NULL
D-ribose	NULL
between	NULL
the	NULL
insulin	NULL
gene	NULL
and	NULL
B-actin	NULL
gene	NULL
promoters	NULL
suggested	NULL
that	NULL
the	NULL
suppression	NULL
of	NULL
the	NULL
promoter	NULL
activity	NULL
should	NULL
be	NULL
attributed	NULL
to	NULL
impairment	NULL
of	NULL
specific	NULL
D-Ribose	NULL
0	NULL
40	NULL
_	NULL
40	NULL
_	NULL
40	NULL
0	NULL
0	NULL
(	NULL
mM	NULL
)	NULL
U	NULL
1	NULL
probe	NULL
(	NULL
2	NULL
0	NULL
)	NULL
(	NULL
5	NULL
0	NULL
)	NULL
only	NULL
Competitor	NULL
-	NULL
=	NULL
-	NULL
=	NULL
w	NULL
M	NULL
(	NULL
x100	NULL
)	NULL
gee	NULL
$	NULL
#	NULL
i	NULL
+	NULL
;	NULL
<	NULL
w	NULL
ig~	NULL
#	NULL
148	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
Figure	NULL
7	NULL
.	NULL

Evaluation	NULL
of	NULL
reversibility	NULL
of	NULL
the	NULL
reduced	NULL
PDX-1	NULL
activity	NULL
caused	NULL
by	NULL
D-ribose	NULL
.	NULL

Gel	NULL
mobility	NULL
shift	NULL
analyses	NULL
were	NULL
performed	NULL
to	NULL
evaluate	NULL
the	NULL
reversibility	NULL
of	NULL
the	NULL
reduction	NULL
in	NULL
PDX-1	NULL
activity	NULL
caused	NULL
by	NULL
D-ribose	NULL
.	NULL

The	NULL
binding	NULL
probe	NULL
for	NULL
the	NULL
human	NULL
insulin	NULL
gene	NULL
A3	NULL
region	NULL
was	NULL
the	NULL
same	NULL
as	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
HIT-T15	NULL
cells	NULL
grown	NULL
for	NULL
5	NULL
,	NULL
7	NULL
,	NULL
and	NULL
10	NULL
d	NULL
under	NULL
various	NULL
conditions	NULL
;	NULL
the	NULL
cells	NULL
were	NULL
kept	NULL
in	NULL
medium	NULL
containing	NULL
0	NULL
mM	NULL
(	NULL
vehicle	NULL
only	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
or	NULL
40	NULL
mM	NULL
D-ribose	NULL
for	NULL
5	NULL
d	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
,	NULL
or	NULL
were	NULL
kept	NULL
for	NULL
5	NULL
d	NULL
in	NULL
40	NULL
mM	NULL
D-ribose	NULL
and	NULL
then	NULL
under	NULL
D-ribose-free	NULL
conditions	NULL
for	NULL
2	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
or	NULL
5	NULL
d	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
.	NULL

The	NULL
binding	NULL
specificity	NULL
was	NULL
evaluated	NULL
using	NULL
the	NULL
unlabeled	NULL
wild-type	NULL
(	NULL
W	NULL
,	NULL
lane	NULL
6	NULL
)	NULL
,	NULL
and	NULL
mutated	NULL
type	NULL
(	NULL
M	NULL
,	NULL
lane	NULL
7	NULL
)	NULL
competitors	NULL
that	NULL
are	NULL
described	NULL
in	NULL
Fig	NULL
.	NULL

5	NULL
.	NULL

Lane	NULL
7	NULL
was	NULL
the	NULL
lane	NULL
in	NULL
which	NULL
no	NULL
nuclear	NULL
extract	NULL
was	NULL
used	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
in	NULL
two	NULL
independent	NULL
experiments	NULL
.	NULL

transcription	NULL
factors	NULL
rather	NULL
than	NULL
to	NULL
more	NULL
generalized	NULL
events	NULL
,	NULL
such	NULL
as	NULL
a	NULL
decrease	NULL
in	NULL
general	NULL
cell	NULL
viability	NULL
.	NULL

Indirect	NULL
support	NULL
of	NULL
our	NULL
present	NULL
observations	NULL
comes	NULL
from	NULL
the	NULL
previous	NULL
reports	NULL
by	NULL
Olson	NULL
et	NULL
al	NULL
.	NULL

(	NULL
8	NULL
)	NULL
and	NULL
Sharma	NULL
et	NULL
al	NULL
.	NULL

(	NULL
9	NULL
)	NULL
,	NULL
which	NULL
suggested	NULL
reduction	NULL
of	NULL
PDX-1/IPF1/STF-1	NULL
(	NULL
25	NULL
,	NULL
26	NULL
)	NULL
activity	NULL
as	NULL
a	NULL
cause	NULL
of	NULL
coreduction	NULL
of	NULL
the	NULL
insulin	NULL
gene	NULL
promoter	NULL
activity	NULL
and	NULL
mRNA	NULL
amounts	NULL
.	NULL

Their	NULL
cell	NULL
model	NULL
for	NULL
glucose	NULL
toxicity	NULL
was	NULL
the	NULL
HIT-T15	NULL
cell	NULL
kept	NULL
under	NULL
high	NULL
glucose	NULL
concentration	NULL
for	NULL
a	NULL
very	NULL
long	NULL
period	NULL
(	NULL
>	NULL
25	NULL
passages	NULL
)	NULL
.	NULL

Despite	NULL
the	NULL
differences	NULL
in	NULL
experimental	NULL
design	NULL
between	NULL
their	NULL
study	NULL
and	NULL
ours	NULL
,	NULL
we	NULL
obtained	NULL
four	NULL
observations	NULL
in	NULL
agreement	NULL
with	NULL
respect	NULL
to	NULL
insulin	NULL
gene	NULL
transcription	NULL
:	NULL
suppression	NULL
of	NULL
the	NULL
promoter	NULL
,	NULL
decreases	NULL
in	NULL
mRNA	NULL
and	NULL
in	NULL
protein	NULL
,	NULL
and	NULL
impairment	NULL
of	NULL
PDX-1	NULL
activity	NULL
.	NULL

The	NULL
use	NULL
of	NULL
aminoguanidine	NULL
and	NULL
NAC	NULL
in	NULL
their	NULL
experimental	NULL
model	NULL
may	NULL
provide	NULL
useful	NULL
information	NULL
for	NULL
understanding	NULL
the	NULL
relative	NULL
physiological	NULL
significance	NULL
of	NULL
glycation	NULL
or	NULL
ROS	NULL
in	NULL
B	NULL
cell	NULL
glucose	NULL
toxicity	NULL
.	NULL

Another	NULL
similarity	NULL
between	NULL
their	NULL
data	NULL
and	NULL
ours	NULL
was	NULL
the	NULL
irreversibility	NULL
of	NULL
the	NULL
phenomena	NULL
(	NULL
38	NULL
)	NULL
;	NULL
the	NULL
D-ribose	NULL
Glycation	NULL
Suppresses	NULL
Insulin	NULL
Gene	NULL
Promoter	NULL
Activity	NULL
149	NULL
dependent	NULL
suppression	NULL
of	NULL
insulin	NULL
mRNA	NULL
as	NULL
well	NULL
as	NULL
of	NULL
the	NULL
DNA-binding	NULL
activity	NULL
of	NULL
PDX-1	NULL
was	NULL
hardly	NULL
recovered	NULL
,	NULL
even	NULL
after	NULL
the	NULL
cells	NULL
had	NULL
been	NULL
kept	NULL
for	NULL
5	NULL
d	NULL
without	NULL
D-ribose	NULL
(	NULL
Figs	NULL
.	NULL

6	NULL
and	NULL
7	NULL
)	NULL
.	NULL

Thus	NULL
it	NULL
is	NULL
likely	NULL
that	NULL
the	NULL
suppressive	NULL
effects	NULL
of	NULL
glycation	NULL
or	NULL
ROS	NULL
on	NULL
the	NULL
insulin	NULL
gene	NULL
transcription	NULL
,	NULL
if	NULL
they	NULL
keep	NULL
occurring	NULL
in	NULL
vivo	NULL
,	NULL
would	NULL
accumulate	NULL
in	NULL
the	NULL
cells	NULL
and	NULL
inhibit	NULL
insulin	NULL
synthesis	NULL
.	NULL

Although	NULL
physiological	NULL
significance	NULL
is	NULL
most	NULL
evident	NULL
for	NULL
PDX-1	NULL
whose	NULL
disruption	NULL
caused	NULL
loss	NULL
of	NULL
the	NULL
pancreas	NULL
in	NULL
mice	NULL
(	NULL
39	NULL
)	NULL
,	NULL
several	NULL
other	NULL
factors	NULL
,	NULL
including	NULL
RIPE3b1	NULL
,	NULL
whose	NULL
activity	NULL
also	NULL
seemed	NULL
to	NULL
be	NULL
inhibited	NULL
after	NULL
chronic	NULL
exposure	NULL
of	NULL
HIT	NULL
cells	NULL
to	NULL
high	NULL
glucose	NULL
concentrations	NULL
(	NULL
8	NULL
,	NULL
9	NULL
)	NULL
,	NULL
are	NULL
also	NULL
involved	NULL
in	NULL
regulation	NULL
of	NULL
the	NULL
insulin	NULL
gene	NULL
.	NULL

Accordingly	NULL
,	NULL
to	NULL
clarify	NULL
all	NULL
of	NULL
the	NULL
aspects	NULL
of	NULL
glycation	NULL
or	NULL
ROS	NULL
effects	NULL
on	NULL
the	NULL
insulin	NULL
gene	NULL
control	NULL
machinery	NULL
,	NULL
the	NULL
physiological	NULL
roles	NULL
of	NULL
each	NULL
transcription	NULL
factor	NULL
in	NULL
determining	NULL
the	NULL
transcription	NULL
rate	NULL
of	NULL
insulin	NULL
gene	NULL
need	NULL
to	NULL
be	NULL
characterized	NULL
.	NULL

In	NULL
summary	NULL
,	NULL
we	NULL
showed	NULL
that	NULL
glycation	NULL
and	NULL
the	NULL
consequent	NULL
increase	NULL
of	NULL
ROS	NULL
are	NULL
potential	NULL
inhibitors	NULL
of	NULL
insulin	NULL
gene	NULL
transcription	NULL
.	NULL

While	NULL
increased	NULL
glycation	NULL
in	NULL
various	NULL
tissues	NULL
was	NULL
identified	NULL
in	NULL
diabetes	NULL
in	NULL
model	NULL
animals	NULL
(	NULL
16	NULL
)	NULL
and	NULL
in	NULL
humans	NULL
(	NULL
15	NULL
,	NULL
40	NULL
)	NULL
,	NULL
similar	NULL
phenomena	NULL
are	NULL
likely	NULL
to	NULL
occur	NULL
in	NULL
vivo	NULL
in	NULL
islets	NULL
.	NULL

The	NULL
glycation-introduced	NULL
HIT-T15	NULL
cells	NULL
used	NULL
in	NULL
this	NULL
study	NULL
may	NULL
offer	NULL
a	NULL
useful	NULL
model	NULL
for	NULL
further	NULL
understanding	NULL
the	NULL
molecular	NULL
basis	NULL
of	NULL
glucose	NULL
toxicity	NULL
to	NULL
pancreatic	NULL
B	NULL
cells	NULL
.	NULL

Acknowledgments	NULL
We	NULL
thank	NULL
Ms.	NULL
Noriko	NULL
Fujita	NULL
for	NULL
the	NULL
excellent	NULL
technical	NULL
assistance	NULL
.	NULL

This	NULL
study	NULL
was	NULL
supported	NULL
in	NULL
part	NULL
by	NULL
a	NULL
Grant-in-Aid	NULL
for	NULL
Scientific	NULL
Research	NULL
(	NULL
to	NULL
R.	NULL
Kawamori	NULL
)	NULL
and	NULL
grants	NULL
from	NULL
Japan	NULL
Diabetes	NULL
Foundation	NULL
(	NULL
to	NULL
Y.	NULL
Kajimoto	NULL
)	NULL
and	NULL
Kyowa	NULL
Hakko	NULL
Kogyo	NULL
Co.	NULL
Ltd.	NULL
(	NULL
to	NULL
Y.	NULL
Ka-jimoto	NULL
and	NULL
Y.	NULL
Yamasaki	NULL
)	NULL
.	NULL

References	NULL
1	NULL
.	NULL

Unger	NULL
,	NULL
R.H.	NULL
,	NULL
and	NULL
S.	NULL
Grundy	NULL
.	NULL

1985	NULL
.	NULL

Hyperglycemia	NULL
as	NULL
an	NULL
inducer	NULL
as	NULL
well	NULL
as	NULL
a	NULL
consequence	NULL
of	NULL
impaired	NULL
islets	NULL
cell	NULL
function	NULL
and	NULL
insulin	NULL
resistance	NULL
:	NULL
implications	NULL
for	NULL
the	NULL
management	NULL
of	NULL
diabetes	NULL
.	NULL

Diabetologia	NULL
.	NULL

28:119-121	NULL
.	NULL

2	NULL
.	NULL

Robertson	NULL
,	NULL
R.P	NULL
.	NULL

1989	NULL
.	NULL

Type	NULL
II	NULL
diabetes	NULL
,	NULL
glucose	NULL
``	NULL
non-sense	NULL
,	NULL
``	NULL
and	NULL
islet	NULL
desensitization	NULL
.	NULL

Diabetes	NULL
.	NULL

38:1501-1505	NULL
.	NULL

3	NULL
.	NULL

Eizirik	NULL
,	NULL
D.L	NULL
.	NULL

,	NULL
G.S	NULL
.	NULL

Korbutt	NULL
,	NULL
and	NULL
C.	NULL
Hellerstrom	NULL
.	NULL

1992	NULL
.	NULL

Prolonged	NULL
exposure	NULL
of	NULL
human	NULL
pancreatic	NULL
islets	NULL
to	NULL
high	NULL
glucose	NULL
concentration	NULL
in	NULL
vitro	NULL
impairs	NULL
the	NULL
B-cell	NULL
function	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

90:1263-1268	NULL
.	NULL

4	NULL
.	NULL

Tokuyama	NULL
,	NULL
Y.	NULL
,	NULL
J.	NULL
Sturis	NULL
,	NULL
A.M.	NULL
DePaoli	NULL
,	NULL
J.	NULL
Takeda	NULL
,	NULL
M.	NULL
Stroffel	NULL
,	NULL
J.	NULL
Tang	NULL
,	NULL
X	NULL
.	NULL

Sun	NULL
,	NULL
K.S	NULL
.	NULL

Polonsky	NULL
,	NULL
and	NULL
G.I	NULL
.	NULL

Bell	NULL
.	NULL

1995	NULL
.	NULL

Evolution	NULL
of	NULL
B-cell	NULL
dysfunction	NULL
in	NULL
the	NULL
male	NULL
Zucker	NULL
diabetic	NULL
fatty	NULL
rat	NULL
.	NULL

Diabetes	NULL
.	NULL

44:1447-1457	NULL
.	NULL

5	NULL
.	NULL

Hummel	NULL
,	NULL
K.P	NULL
.	NULL

,	NULL
D.L	NULL
.	NULL

Coleman	NULL
,	NULL
and	NULL
P.W	NULL
.	NULL

Lane	NULL
.	NULL

1972	NULL
.	NULL

The	NULL
Influence	NULL
of	NULL
genetic	NULL
background	NULL
of	NULL
expression	NULL
of	NULL
mutations	NULL
at	NULL
the	NULL
diabetes	NULL
locus	NULL
in	NULL
the	NULL
mouse	NULL
.	NULL

I.	NULL
C57BL/KsJ	NULL
and	NULL
C57BL/6J	NULL
strains	NULL
.	NULL

Biochem	NULL
.	NULL

Genet	NULL
.	NULL

7:1-13	NULL
.	NULL

6	NULL
.	NULL

Robertson	NULL
,	NULL
R.P	NULL
.	NULL

,	NULL
H.J	NULL
.	NULL

Zhang	NULL
,	NULL
KL	NULL
.	NULL

Pyzdrowski	NULL
,	NULL
and	NULL
T.F	NULL
.	NULL

Walseth	NULL
.	NULL

1992	NULL
.	NULL

Preservation	NULL
of	NULL
insulin	NULL
mRNA	NULL
levels	NULL
and	NULL
insulin	NULL
secretion	NULL
in	NULL
HIT	NULL
cells	NULL
by	NULL
avoidance	NULL
of	NULL
chronic	NULL
exposure	NULL
to	NULL
high	NULL
glucose	NULL
concentrations	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

90:320-325	NULL
.	NULL

7	NULL
.	NULL

Olson	NULL
,	NULL
LK	NULL
.	NULL

,	NULL
J.B.	NULL
Redmon	NULL
,	NULL
H.C.	NULL
Towle	NULL
,	NULL
and	NULL
P.	NULL
Robertson	NULL
.	NULL

1993	NULL
.	NULL

Chronic	NULL
exposure	NULL
of	NULL
HIT	NULL
cells	NULL
to	NULL
high	NULL
glucose	NULL
concentrations	NULL
paradoxically	NULL
decreases	NULL
insulin	NULL
gene	NULL
transcription	NULL
and	NULL
alters	NULL
binding	NULL
of	NULL
insulin	NULL
gene	NULL
regulatory	NULL
protein	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

92:514-519	NULL
.	NULL

8	NULL
.	NULL

Olson	NULL
,	NULL
LK	NULL
.	NULL

,	NULL
A.	NULL
Sharma	NULL
,	NULL
M.	NULL
Peshavaria	NULL
,	NULL
C.V.E	NULL
.	NULL

Wright	NULL
,	NULL
H.C.	NULL
Towle	NULL
,	NULL
RP	NULL
.	NULL

Robertson	NULL
.	NULL

and	NULL
R.	NULL
Stein	NULL
.	NULL

1995	NULL
.	NULL

Reduction	NULL
of	NULL
insulin	NULL
gene	NULL
transcription	NULL
in	NULL
HIT-T15	NULL
B-cells	NULL
chronically	NULL
exposed	NULL
to	NULL
a	NULL
supraphysiologic	NULL
glucose	NULL
concentration	NULL
is	NULL
associated	NULL
with	NULL
loss	NULL
of	NULL
STF-1	NULL
transcription	NULL
factor	NULL
expression	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

92:9127-9131	NULL
.	NULL

9	NULL
.	NULL

Sharma	NULL
,	NULL
A.	NULL
,	NULL
LK	NULL
.	NULL

Olson	NULL
,	NULL
R.P	NULL
.	NULL

Robertson	NULL
,	NULL
and	NULL
R.	NULL
Stein	NULL
.	NULL

1995	NULL
.	NULL

The	NULL
reduction	NULL
of	NULL
insulin	NULL
gene	NULL
transcription	NULL
in	NULL
HIT-T15	NULL
B	NULL
cells	NULL
chronically	NULL
exposed	NULL
to	NULL
high	NULL
glucose	NULL
concentration	NULL
is	NULL
associated	NULL
with	NULL
loss	NULL
of	NULL
RIPE3b1	NULL
and	NULL
STF-1	NULL
transcription	NULL
factor	NULL
expression	NULL
.	NULL

Mol	NULL
.	NULL

Endocrinol	NULL
.	NULL

9:1127-1134	NULL
.	NULL

10	NULL
.	NULL

Clements	NULL
,	NULL
R.S	NULL
.	NULL

,	NULL
Jr.	NULL
1986	NULL
.	NULL

The	NULL
polyol	NULL
pathway	NULL
.	NULL

A	NULL
historical	NULL
review	NULL
.	NULL

Drugs	NULL
.	NULL

32	NULL
(	NULL
Suppl	NULL
.	NULL

2	NULL
)	NULL
:3-5	NULL
.	NULL

11	NULL
.	NULL

Eble	NULL
,	NULL
A.S.	NULL
,	NULL
S.R	NULL
.	NULL

Thorpe	NULL
,	NULL
and	NULL
J.W	NULL
.	NULL

Baynes	NULL
.	NULL

1983	NULL
.	NULL

Nonenzymatic	NULL
glucosy-lation	NULL
and	NULL
glucose-dependent	NULL
cross-linking	NULL
of	NULL
protein	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

258:9406-9412	NULL
.	NULL

12	NULL
.	NULL

Brownlee	NULL
,	NULL
M.	NULL
,	NULL
H.	NULL
Vlassara	NULL
,	NULL
and	NULL
A.	NULL
Cerami	NULL
.	NULL

1984	NULL
.	NULL

Nonenzymatic	NULL
glyco-	NULL
150	NULL
_	NULL
Matsuoka	NULL
et	NULL
al	NULL
.	NULL

sylation	NULL
and	NULL
the	NULL
pathogenesis	NULL
of	NULL
diabetic	NULL
complications	NULL
.	NULL

Ann	NULL
.	NULL

Intern	NULL
.	NULL

Med	NULL
.	NULL

101	NULL
:	NULL
527-537	NULL
.	NULL

13	NULL
.	NULL

Njoroge	NULL
,	NULL
F.J.	NULL
,	NULL
and	NULL
V.M	NULL
.	NULL

Monnier	NULL
.	NULL

1989	NULL
.	NULL

The	NULL
chemistry	NULL
of	NULL
the	NULL
Maillard	NULL
reaction	NULL
under	NULL
physiological	NULL
conditions	NULL
:	NULL
a	NULL
review	NULL
.	NULL

Prog	NULL
.	NULL

Clin	NULL
.	NULL

Biol	NULL
.	NULL

Res	NULL
.	NULL

304:85-107	NULL
.	NULL

14	NULL
.	NULL

Duhaiman	NULL
,	NULL
A.S.	NULL
,	NULL
N.	NULL
Rabbani	NULL
,	NULL
and	NULL
E.	NULL
Cotlier	NULL
.	NULL

1990	NULL
.	NULL

Camel	NULL
lens	NULL
crystal-lins	NULL
glycosylation	NULL
and	NULL
high	NULL
molecular	NULL
weight	NULL
aggregate	NULL
formation	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
ferrous	NULL
ions	NULL
and	NULL
glucose	NULL
.	NULL

Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Commun	NULL
.	NULL

173:823-832	NULL
.	NULL

15	NULL
.	NULL

Monnier	NULL
,	NULL
V.M	NULL
.	NULL

,	NULL
R.R	NULL
.	NULL

Kohn	NULL
,	NULL
and	NULL
A.	NULL
Cerami	NULL
.	NULL

1984	NULL
.	NULL

Accelerated	NULL
age-related	NULL
browning	NULL
of	NULL
human	NULL
collagen	NULL
in	NULL
diabetes	NULL
mellitus	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

81:583-587	NULL
.	NULL

16	NULL
.	NULL

Myint	NULL
,	NULL
T.	NULL
,	NULL
S.	NULL
Hoshi	NULL
,	NULL
T.	NULL
Ookawara	NULL
,	NULL
N.	NULL
Miyazawa	NULL
,	NULL
K.	NULL
Suzuki	NULL
,	NULL
and	NULL
N.	NULL
Tani-guchi	NULL
.	NULL

1995	NULL
.	NULL

Immunological	NULL
detection	NULL
of	NULL
glycated	NULL
proteins	NULL
in	NULL
normal	NULL
and	NULL
streptozotocin-induced	NULL
diabetic	NULL
rats	NULL
using	NULL
anti	NULL
hexitol-lysine	NULL
IgG	NULL
.	NULL

Biochim	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
.	NULL

1272:73-79	NULL
.	NULL

17	NULL
.	NULL

Sakurai	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
S.	NULL
Tsuchiya	NULL
.	NULL

1988	NULL
.	NULL

Superoxide	NULL
production	NULL
from	NULL
nonenzymatically	NULL
glycation	NULL
protein	NULL
.	NULL

FEBS	NULL
Left	NULL
.	NULL

236:406-410	NULL
.	NULL

18	NULL
.	NULL

Baynes	NULL
,	NULL
J.	NULL
W.	NULL
1991	NULL
.	NULL

Role	NULL
of	NULL
oxidative	NULL
stress	NULL
in	NULL
development	NULL
of	NULL
complications	NULL
in	NULL
diabetes	NULL
.	NULL

Diabetes	NULL
.	NULL

40:405-412	NULL
.	NULL

19	NULL
.	NULL

Franklin	NULL
,	NULL
H.B	NULL
.	NULL

,	NULL
and	NULL
P.J	NULL
.	NULL

Higgins	NULL
.	NULL

1981	NULL
.	NULL

Reaction	NULL
of	NULL
monosaccharides	NULL
with	NULL
proteins	NULL
:	NULL
possible	NULL
evolutionary	NULL
significance	NULL
.	NULL

Science	NULL
(	NULL
Wash.	NULL
DC	NULL
)	NULL
.	NULL

213:222-224	NULL
.	NULL

20	NULL
.	NULL

Hasegawa	NULL
,	NULL
G.	NULL
,	NULL
A.J	NULL
.	NULL

Hunter	NULL
,	NULL
and	NULL
A.S.	NULL
Charonis	NULL
.	NULL

1995	NULL
.	NULL

Matrix	NULL
nonenzymatic	NULL
glycosylation	NULL
leads	NULL
to	NULL
altered	NULL
cellular	NULL
phenotype	NULL
and	NULL
intracellular	NULL
ty-rosine	NULL
phosphorylation	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270:3278-3283	NULL
.	NULL

21	NULL
.	NULL

Brownlee	NULL
,	NULL
M.	NULL
,	NULL
H.	NULL
Vlassara	NULL
,	NULL
A.	NULL
Kooney	NULL
,	NULL
P.	NULL
Ulrich	NULL
,	NULL
and	NULL
A.	NULL
Cerami	NULL
.	NULL

1986	NULL
.	NULL

Aminoguanidine	NULL
prevents	NULL
diabetes-induced	NULL
arterial	NULL
wall	NULL
protein	NULL
cross-linking	NULL
.	NULL

Science	NULL
(	NULL
Wash.	NULL
DC	NULL
)	NULL
.	NULL

232:1629-1632	NULL
.	NULL

22	NULL
.	NULL

Edelstein	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
M.	NULL
Brownlee	NULL
.	NULL

1992	NULL
.	NULL

Mechanistic	NULL
studies	NULL
of	NULL
advanced	NULL
glycosylation	NULL
by	NULL
aminoguanidine	NULL
.	NULL

Diabetes	NULL
.	NULL

41:26-29	NULL
.	NULL

23	NULL
.	NULL

Meister	NULL
,	NULL
A	NULL
.	NULL

1988	NULL
.	NULL

Glutathione	NULL
metabolism	NULL
and	NULL
its	NULL
selective	NULL
modifica-tion	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

263:17205-17208	NULL
.	NULL

24	NULL
.	NULL

Ratan	NULL
,	NULL
RR	NULL
.	NULL

,	NULL
T.H	NULL
.	NULL

Murphy	NULL
,	NULL
and	NULL
J.M	NULL
.	NULL

Baraban	NULL
.	NULL

1994	NULL
.	NULL

Macromolecular	NULL
synthesis	NULL
inhibitors	NULL
prevent	NULL
oxidative	NULL
stress-induced	NULL
apoptosis	NULL
in	NULL
embrionic	NULL
cortical	NULL
neurons	NULL
by	NULL
shunting	NULL
cysteine	NULL
from	NULL
protein	NULL
synthesis	NULL
to	NULL
glutathione	NULL
.	NULL

J.	NULL
Neurosci	NULL
.	NULL

14:4385-4392	NULL
.	NULL

25	NULL
.	NULL

Ohlsson	NULL
,	NULL
H.	NULL
,	NULL
K.	NULL
Karlsson	NULL
,	NULL
and	NULL
T.	NULL
Edlund	NULL
.	NULL

1993	NULL
.	NULL

IPF1	NULL
,	NULL
a	NULL
homeodomain-containing	NULL
transactivator	NULL
of	NULL
the	NULL
insulin	NULL
gene	NULL
.	NULL

EMBO	NULL
(	NULL
Eur	NULL
.	NULL

Mol	NULL
.	NULL

Biol	NULL
.	NULL

Organ	NULL
.	NULL
)	NULL

J	NULL
.	NULL

12:4251-4259	NULL
.	NULL

26	NULL
.	NULL

Leonard	NULL
,	NULL
J.	NULL
,	NULL
B	NULL
.	NULL

Peers	NULL
,	NULL
T.	NULL
Johnson	NULL
,	NULL
K.	NULL
Ferreri	NULL
,	NULL
S.	NULL
Lee	NULL
,	NULL
and	NULL
MR.	NULL
Mont-miny	NULL
.	NULL

1993	NULL
.	NULL

Characterization	NULL
of	NULL
somatostatin	NULL
transactivating	NULL
factor-1	NULL
,	NULL
a	NULL
novel	NULL
homeobox	NULL
factor	NULL
that	NULL
stimulates	NULL
somatostatin	NULL
expression	NULL
in	NULL
pancreatic	NULL
islet	NULL
cells	NULL
.	NULL

Mol	NULL
.	NULL

Endocrinol	NULL
.	NULL

7:1275-1283	NULL
.	NULL

27	NULL
.	NULL

Sambrook	NULL
,	NULL
J.	NULL
,	NULL
E.F.	NULL
Fritsch	NULL
,	NULL
and	NULL
T.	NULL
Maniatis	NULL
.	NULL

1989	NULL
.	NULL

Molecular	NULL
Cloning	NULL
:	NULL
A	NULL
Laboratory	NULL
Mannual	NULL
.	NULL

2nd	NULL
Ed	NULL
.	NULL

Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
,	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
,	NULL
NY	NULL
.	NULL

28	NULL
.	NULL

Maxwell	NULL
,	NULL
LH	NULL
.	NULL

,	NULL
G.S	NULL
.	NULL

Harrison	NULL
,	NULL
W.M	NULL
.	NULL

Wood	NULL
,	NULL
F.	NULL
Maxwell	NULL
.	NULL

1989	NULL
.	NULL

A	NULL
DNA	NULL
cassette	NULL
containing	NULL
a	NULL
trimerized	NULL
SV40	NULL
polyadenylation	NULL
signal	NULL
which	NULL
efficiently	NULL
blocks	NULL
spurious	NULL
plasmid-initiated	NULL
transcription	NULL
.	NULL

Biotechniques	NULL
.	NULL

7:276-280	NULL
.	NULL

29	NULL
.	NULL

Leavitt	NULL
,	NULL
J.	NULL
,	NULL
P.	NULL
Gunning	NULL
,	NULL
P.	NULL
Porreca	NULL
,	NULL
S.Y	NULL
.	NULL

Ng	NULL
,	NULL
C.S	NULL
.	NULL

Lin	NULL
,	NULL
and	NULL
L.	NULL
Kedes	NULL
.	NULL

1984	NULL
.	NULL

Molecular	NULL
cloning	NULL
and	NULL
characterization	NULL
of	NULL
mutant	NULL
and	NULL
wild-type	NULL
human	NULL
beta-actin	NULL
genes	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

4:1961-1969	NULL
.	NULL

30	NULL
.	NULL

Watada	NULL
,	NULL
H.	NULL
,	NULL
Y.	NULL
Kajimoto	NULL
,	NULL
Y.	NULL
Umayahara	NULL
,	NULL
T.	NULL
Matsuoka	NULL
,	NULL
H.	NULL
Kaneto	NULL
,	NULL
Y.	NULL
Fujitani	NULL
,	NULL
T.	NULL
Kamada	NULL
,	NULL
R.	NULL
Kawamori	NULL
,	NULL
and	NULL
Y.	NULL
Yamasaki	NULL
.	NULL

1996	NULL
.	NULL

The	NULL
human	NULL
glucokinase	NULL
gene	NULL
B-cell-type	NULL
promoter	NULL
:	NULL
an	NULL
essential	NULL
role	NULL
of	NULL
insulin	NULL
promoter	NULL
factor	NULL
1	NULL
(	NULL
IPF1	NULL
)	NULL
/PDX-1	NULL
in	NULL
its	NULL
activation	NULL
in	NULL
HIT-T15	NULL
cells	NULL
.	NULL

Diabetes	NULL
.	NULL

45:1478-1488	NULL
.	NULL

31	NULL
.	NULL

Soares	NULL
,	NULL
M.B	NULL
.	NULL

,	NULL
E.	NULL
Schon	NULL
,	NULL
A.	NULL
Henderson	NULL
,	NULL
S.K	NULL
.	NULL

Karathanasis	NULL
,	NULL
R.	NULL
Cate	NULL
,	NULL
S.	NULL
Zeitlin	NULL
,	NULL
J.	NULL
Chirgwin	NULL
,	NULL
and	NULL
A.	NULL
Efstratiadis	NULL
.	NULL

1985	NULL
.	NULL

RNA-mediated	NULL
gene	NULL
duplica-tion	NULL
:	NULL
the	NULL
rat	NULL
preproinsulin	NULL
I	NULL
gene	NULL
is	NULL
a	NULL
functional	NULL
retroposon	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

5	NULL
:	NULL
2090-2103	NULL
.	NULL

32	NULL
.	NULL

Sadowski	NULL
,	NULL
H.B	NULL
.	NULL

,	NULL
and	NULL
M.Z	NULL
.	NULL

Gilman	NULL
.	NULL

1993	NULL
.	NULL

Cell-free	NULL
activation	NULL
of	NULL
a	NULL
DNA-binding	NULL
protein	NULL
by	NULL
epidermal	NULL
growth	NULL
factor	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

.	NULL

362:79-83	NULL
.	NULL

33	NULL
.	NULL

Hunt	NULL
,	NULL
J.V	NULL
.	NULL

,	NULL
R.T.	NULL
Dean	NULL
,	NULL
and	NULL
S.P	NULL
.	NULL

Wolff	NULL
.	NULL

1988	NULL
.	NULL

Hydroxyl	NULL
radical	NULL
production	NULL
and	NULL
autoxidative	NULL
glycosylation	NULL
.	NULL

Biochem	NULL
.	NULL

J	NULL
.	NULL

256:205-212	NULL
.	NULL

34	NULL
.	NULL

Trouche	NULL
,	NULL
D.	NULL
,	NULL
M.	NULL
Grigoriev	NULL
,	NULL
P.	NULL
Robin	NULL
,	NULL
and	NULL
A.H.	NULL
Bellan	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
serum	NULL
unresponsive	NULL
Rous	NULL
sarcoma	NULL
virus	NULL
promoter	NULL
sustains	NULL
a	NULL
high	NULL
serum	NULL
response	NULL
factor-dependent	NULL
transcription	NULL
in	NULL
vitro	NULL
.	NULL

Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Commun	NULL
.	NULL

196:611-618	NULL
.	NULL

35	NULL
.	NULL

Nose	NULL
,	NULL
K.	NULL
,	NULL
M.	NULL
Shibanuma	NULL
,	NULL
K.	NULL
Kikuchi	NULL
,	NULL
H.	NULL
Kageyama	NULL
,	NULL
S.	NULL
Sakiyama	NULL
,	NULL
and	NULL
T.	NULL
Kuroki	NULL
.	NULL

1991	NULL
.	NULL

Transcriptional	NULL
activation	NULL
of	NULL
early-response	NULL
genes	NULL
by	NULL
hydrogen	NULL
peroxide	NULL
in	NULL
a	NULL
mouse	NULL
osteoblastic	NULL
cell	NULL
line	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Biochem	NULL
.	NULL

201:99-106	NULL
.	NULL

36	NULL
.	NULL

Kashimura	NULL
,	NULL
N.	NULL
,	NULL
J.	NULL
Morita	NULL
,	NULL
and	NULL
T.	NULL
Komano	NULL
.	NULL

1979	NULL
.	NULL

Autoxidation	NULL
and	NULL
phago-cidal	NULL
action	NULL
of	NULL
some	NULL
reducing	NULL
sugar	NULL
phosphate	NULL
.	NULL

Carbohyd	NULL
.	NULL

Res	NULL
.	NULL

70	NULL
:	NULL
C3-C7	NULL
.	NULL

37	NULL
.	NULL

Tajiri	NULL
,	NULL
Y.	NULL
,	NULL
and	NULL
V.E	NULL
.	NULL

Grill	NULL
.	NULL

1996	NULL
.	NULL

Advanced	NULL
glycosylation	NULL
end	NULL
products	NULL
in	NULL
pancreatic	NULL
islets	NULL
:	NULL
coupling	NULL
to	NULL
high	NULL
glucose	NULL
exposure	NULL
and	NULL
deterioration	NULL
of	NULL
B-cell	NULL
function	NULL
.	NULL

Diabetes	NULL
.	NULL

45	NULL
(	NULL
Suppl	NULL
.	NULL

2	NULL
)	NULL
:195A	NULL
.	NULL

38	NULL
.	NULL

Robertson	NULL
,	NULL
R.P	NULL
.	NULL

,	NULL
L.K	NULL
.	NULL

Olson	NULL
,	NULL
and	NULL
H.J	NULL
.	NULL

Zhang	NULL
.	NULL

1994	NULL
.	NULL

Differentiating	NULL
glucose	NULL
toxicity	NULL
from	NULL
glucose	NULL
desensitization	NULL
:	NULL
a	NULL
new	NULL
message	NULL
from	NULL
the	NULL
insulin	NULL
gene	NULL
.	NULL

Diabetes	NULL
.	NULL

43:1085-1089	NULL
.	NULL

39	NULL
.	NULL

Jonsson	NULL
,	NULL
J.	NULL
,	NULL
L.	NULL
Carlsson	NULL
,	NULL
T.	NULL
Edlund	NULL
,	NULL
and	NULL
H.	NULL
Edlund	NULL
.	NULL

1984	NULL
.	NULL

Insulin-pro-moter	NULL
factor	NULL
1	NULL
is	NULL
required	NULL
for	NULL
pancreas	NULL
development	NULL
in	NULL
mice	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

.	NULL

371:606-609	NULL
.	NULL

40	NULL
.	NULL

Sell	NULL
,	NULL
D.R	NULL
.	NULL

,	NULL
and	NULL
V.M	NULL
.	NULL

Monnier	NULL
.	NULL

1990	NULL
.	NULL

End-stage	NULL
renal	NULL
disease	NULL
and	NULL
diabetes	NULL
catalyze	NULL
the	NULL
formation	NULL
of	NULL
a	NULL
pentose-derived	NULL
crosslink	NULL
from	NULL
aging	NULL
human	NULL
col-lagen	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

85:380-384	NULL
.	NULL

